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Bacillus amyloliquefaciens FZB42 is a Gram-positive, pathogen-suppressing and plant-
growth promoting rhizobacterium. It has recently been shown that GFP-labelled FZB42 was 
able to colonize the roots of three different plant genera. Apart from this ability, it produces a 
vast array of secondary metabolites, which includes both ribosomal and non-ribosomal pep-
tides. Amylocyclicin A and plantazolicin are ribosomally synthesized antimicrobials by 
FZB42 which were recently identified.  
In case of non-ribosomally synthesized peptides, five gene clusters (srf, bmy, fen, nrs, and 
dhb) direct the biosynthesis of lipopeptides, and three other gene clusters (mln, bae, and dfn) 
are involved in the synthesis of antibacterial polyketides. In addition to this, a dipeptide anti-
biotic bacilysin is encoded by a single operon (bacABCDE) along with the adjacent, ywfGH 
genes. It is a simple peptide antibiotic consisting of L-alanine and L-anticapsin as its molecu-
lar backbone. 
In this work, the transcriptional activation and regulation of bacilysin biosynthesis were stud-
ied at the promoters of bac and ywfH genes. The promoter of bacilysin was identified using 5'-
deletion analysis. Sigma factor A (σA) was found to start transcription via conserved promoter 
elements (-10 and -35) of bac and ywfH genes. lacZ reporter fusion studies were performed in 
wild type and regulatory mutants. The results show the involvement of transcriptional regula-
tors to activate the expression of bacilysin genes. Several global regulators such as DegU, 
ComA, Hpr and AbrB were identified and found to influence gene expression. In particular, I 
confirmed DegU binding in bac and ywfH promoters using radioactive DNase I footprinting.  
Furthermore, Hpr, a transition state regulator was found negatively to control bacilysin bio-
synthesis. Hpr binding to bac promoter was demonstrated using radioactive DNase I foot-
printing. Remarkably, Hpr does not influence the promoter of the monocistronic gene, ywfH. 
The other transcriptional regulators, such as ComA and AbrB, were correlated indirectly to 
affect the gene expression of bacilysin via DegQ and Hpr, respectively. The gene regulation of 
hpr was studied in this work. It was demonstrated that AbrB, a global regulator, directly con-
trols the promoter of the hpr gene. However, the consensus sequence for AbrB binding was 
not identified, since it covers the entire promoter region in the DNA-protein interaction study. 
 
 
To conclude, this study provides new information regarding the genetic regulation of bacilysin 
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Bacilli are ubiquitous and successful among bacteria. They are members of division firmicu-
tes. The survival success of the many species of this genus is mainly due to the physiological 
abilities that allow living in a wide range of environments. Today, there are 65 valid species of 
Bacillus clustered in at least five different groups based on 16S rRNA analysis [1-2]. Since 
Bacillus can thrive in a wide range of environments, it is difficult to characterize them into 
particular ecological niche [3]. Each cell forms a single endospore under nutritional depriva-
tion or adverse climatic conditions. The spores are resistant to heat, cold, radiation, desicca-
tion and disinfectants and they are carried to long distance. Upon suitable conditions, the 
spores germinate into viable cells. 
During starvation, Bacillus species not only activate the sporulation process, but also other 
regulons, such as competence development, the production of extracellular degradative en-
zymes and antibiotics are induced. These phenomena reflect the ability of Bacillus to adjust 
rapidly to a changing environment. The production of antibiotics is considered to be a major 
step in enhancing the competitiveness of producing organism under an environment with lim-
ited resource [4]. 
Bacillus produces a wide variety of antibiotics and extracellular degradative enzymes. The 
synthesis of these antibiotics and enzymes are temporally controlled and subject to regulation 
by a large number of global regulators such as DegU, ComA, ScoC, SinR and AbrB [5-8]. 
The production of antibiotics by Bacillus includes NRPs, PKs, dipeptide antibiotics, and sev-
eral other secondary metabolites [9]. The regulations of these secondary metabolites are car-
ried along with other regulons such as competence development and sporulation. It has been 
reported that the production of these secondary metabolites promotes plant growth in the vi-
cinity of root [10-12]. 
1.1 Bacillus amyloliquefaciens FZB42 
The Bacillus strains of plant growth promoting activity were isolated from plant-pathogen-
infested soil [13]. B. subtilis can be differentiated from B. amyloliquefaciens by its ability to 
produce lipase from lactose [14]. B. amyloliquefaciens is a naturally occurring rod shaped, 




where they colonize and mutually benefit plant-microbe interaction. Initially, it was isolated 
and used industrially for the production of α-amylase to liquefy starch [15]. The commercially 
available strain FZB24 is the closest relative of B. amyloliquefaciens [16]. The genome se-
quencing of B. amyloliquefaciens strain FZB42 was completed in 2007 by Chen et al. The 
circular chromosome of this genome is 3,918,589 bp and is smaller than those of B. subtilis 
168 and B. licheniformis. 
The smaller size of the genome is due to the absence of prophage islands which are abundant 
in other Bacillus species. There are 214 unique genes present in this strain clustered in 17 ge-
nomic DNA islands. Apart from the unique genes, B. amyloliquefaciens FZB42 harbour many 
genes for unusual sugar metabolic pathway involved in degrading the plant sugars which are 
available around plant roots. B. amyloliquefaciens FZB42 has gene for a novel sigma factor 
and its corresponding gene for anti-sigma factor, whereas the genes for other common sigma 
factors are similar to the genes of B. subtilis 168 [17]. A successful root colonizing involves 
the formation of sessile, multicellular colonies called biofilm. B. amyloliquefaciens FZB42 
forms robust pellicles in the liquid-air interface, whereas, B. subtilis168 forms weak pellicles. 
There are three unique genes present in B. amyloliquefaciens FZB42 which are involved in 
surface adhesion or biofilm formation. The biofilm formation at the root surface has also been 
demonstrated by using SEM and TEM (Fan Ben pers.communication). 
B. amyloliquefaciens FZB42 has nine giant gene clusters involved in biosynthesis of second-
ary metabolites. Nearly 8.5% of the genome is devoted to the production of antibiotics and 
siderophores not involving ribosomes. Nine clusters direct the synthesis of antimicrobial pep-
tides and polyketides by modularly organized mega-enzyme complexes of non-ribosomal 
peptide synthetases (NRPS) and polyketide synthases (PKS). Four clusters bmyD, pks2, pks3 
and nrs are not found in B. subtilis 168 [17], but the genes (bac) for bacilysin biosynthesis are 
conserved in both species of Bacillus. For the production of other NRP and polyketides, Sfp is 
required. Sfp is an enzyme that transfers 4’-phosphopantetheine from coenzyme A to carrier 
proteins of nascent peptide or polyketide chains. All the gene clusters have been assigned with 
biological functions [18]. 




FZB42 makes this organism competent in the rhizosphere and helps it to act against phyto-
pathogenic viruses, bacteria, fungi, and nematodes in the rhizosphere. Most of these peptides 
are produced at sophisticated modular multienzyme complexes and contain a β-amino or β-
hydroxy fatty acid component that is integrated into the peptide moiety. Gene clusters in-
volved in surfactin, bacillomycinD, and fengycin biosynthesis were identified in the genome 
of FZB42. Bacillomycin D and fengycin are shown to act in a synergistic manner, enabling 
the bacteria to cope with competing organisms within plant rhizosphere [18]. The functional 
characterization of the gene clusters involved in lipopeptide synthesis was performed by using 
MALDI-TOF- MS [19]. Due to the enormous capacity of FZB42 to produce a wide range of 
antimicrobial peptides and antibiotics, it has been used as biocontrol agent to improve plant 
growth promotion (RhizoVital®42-AbiTEP GmbH). 
1.2 Antibiotics 
Antibiotics are produced by a large number of bacterial species as secondary metabolites. 
They are useful to the producing organism even at very low concentrations [20]. Antibiotics 
have a wide range of applications in the fields of chemotherapy, plant pathology, food preser-
vation, veterinary medicine and as research tools in biochemistry and molecular biology. The 
production of antibiotics by bacteria also benefits plant-microbe interaction by warding off 
plant pathogenic fungi and bacteria and thereby promotes the health of plants [21]. At present, 
approx.7000 antimicrobial compounds are known and hundreds of them are produced com-
mercially by microbial fermentation processes [22]. A list of antibiotics and their producing 
microorganism are given in the Table 1. 
Table 1: Antibiotics and its Producers 
Penicillium Penicillin 
B. licheniformis  Bacitracin 
Cephalosporium acremonium  Cephalosporin 
Nocardia uniformis  Norcardins 




S. antibioticus  Mitomycin 
S. erythreus  Erythromycin 
S. griseus  Streptomycin, cycloheximide  
S. virginae  Virginiamycin 
B. subtilis 168 Ericin, bacilysin, subtilin, sublancin, mersacidin, subtilosin A 
B. amyloliquefaciens FZB42 Bacillaene, bacillomycinD, bacilysin, macrolactin, fengycin, difficidin 
 
Peptide antibiotics are produced either by gene encoded ribosomal synthesis or via multimod-
ular enzyme templates as non-ribosomally synthesized peptides. The path of these peptides is 
based on their evolutionary acceptance of genes over the period. 
In general, syntheses of proteins are carried out by ribosomes. The message carried by mRNA 
is translated into protein using ribosomes. The translation machinery is one of the big com-
plexes in the cell containing a large variety of proteins and RNAs [23-24]. Transfer RNA 
(tRNA) functions as an adaptor molecule between the codon on mRNA and the respective 
amino acid specified by the codon. The tRNAs are aminoacylated by aminoacyl-tRNA syn-
thetases [25]. The decoding of mRNA and peptide synthesis takes place on ribosomes and 
carries out protein synthesis in the cytosol [26-27]. All phases of protein synthesis, i.e., initia-
tion, elongation, and termination require the action of translation factors that interact with the 
ribosome at defined stages of translation [28]. 
The endospore-forming rhizobacterium Bacillus species produces two dozens of antibiotics 
with an amazing variety of structures [9]. Their antagonistic activity extends to a wide range 
of potential phytopathogens, including bacteria, fungi and oomycetes [29]. Peptide antibiotics 
represent one of the major classes of antibiotics. The predominant bioactive molecules include 
either ribosomally synthesized and post-translationally modified (lantibiotics and lantibiotic-
like peptides) or non-ribosomally generated antibiotics. Non-peptidic compounds such as 




B. subtilis has devoted 350kb of genes for the antibiotic production which accounts for 3-5% 
of its genome capacity [30]. 
The structures of lantibiotics are rigid due to their unusual D-amino acids. The thioether link-
ages make them resistant to proteolysis and oxidation. Peptide antibiotics with thioether link-
ages are named as ‘Lantibiotics’ (lanthionine containing antibiotics) [31]. The mechanism 
behind lanthionine formation includes dehydration of serine and threonine residues, respec-
tively, and subsequent addition of neighbouring cysteine thiol groups during the post-
translational modification. Based on their structural properties, lantibiotics have been grouped 
into type A lantibiotics (21–38 amino acid residues), killing Gram-positive bacteria by form-
ing voltage dependent pores in cytoplasmic membranes, [32], whereas, type B lantibiotics 
exhibit more globular structures and inhibit cell wall biosynthesis by forming complex with 
lipid II. 
 
Figure 1: Classification of lantibiotics in groups "A" and "B" according to the charges, conformation, and bio-
logical activity [32]. 
The lantibiotic producers are always self-protected. They carry immunity genes within its 
operon. The ATP binding cassette (ABC) transporter exports the lantibiotic from the cyto-
plasmic membrane into the extracellular space [9, 32]. Subtilin, a 32 amino acid pentacyclic 
lantibiotic is produced by a gene cluster containing ten genes encoding for prepeptide, trans-
portation and immunity [33-35]. Its biosynthesis is positively feedback regulated. The growth 





Lantibiotics are flexible as it could be seen in the production of ericin. Ericin is similar to sub-
tilin, except for four amino acids differing in former. Its biological activity is comparable to 
that of subtilin [38]. It is produced by two structural genes, eriA and eriS. Ericin S and ericin 
A are produced by common synthetases, EriBC. Ericin A is a variant of ericin S except for the 
16 amino acid substitutions and a different ring organization. Mersacidin belongs to type B 
lantibiotics and exhibits globular structure. It is produced by the structural gene mrsA. The 
operon includes genes for post-translational modification, immunity and transport. Mersacidin 
is controlled by the regulators MrsR2/K2. [39]. Expression of mRNA occurs in early station-
ary phase, however, the link between mersacidin and growth regulation is not yet clear. MrsD, 
a member of the homo-oligomeric flavin-containing cysteine decarboxylases (HFCD) family, 
modifies the C-terminus of cysteine of the mersacidin prepeptide. The dodecameric MrsD and 
its close relative EpiD are involved in epidermin biosynthesis, representing the only example 
of lantibiotic modifying enzymes with known three-dimensional structure [40]. 
Bacillus produces unusual lantibiotic such as sublancin 168. It has a β-methyllanthionine and 
two disulfide bridges which are unusual for lantibiotics [41-42]. The structural gene for sub-
lancin was acquired from a temperate bacteriophage SPβ. Even though the sublancin gene 
cluster is not essential for the survival of B. subtilis, one attractive hypothesis is that sublancin 
might be contributing to the survival of the bacteriophage [41]. For example, sublancin kills 
only non-lysogenized cells, thus enriching the percent of a lysogenized B. subtilis population 
[43]. Subtilosin A, an unusual antibiotic, is produced by several Bacillus strains. It contains a 
macrocyclic ring structure with three inter-residual linkages, and thioether bonds between 
cysteine sulphurs and amino acid alpha-carbons [44-46]. The unusual lantibiotics can act 
against a variety of Gram positive bacteria including Listeria [47-49]. 
1.3 Non- ribosomal peptides 
Non-ribosomal synthesis of peptides is widespread among bacteria and fungi [50-51]. Many 
useful antibiotics are produced via the non-ribosomal path. NRPSs are composed of large 
multi-enzymatic, modularly arranged catalytic domains which perform all necessary steps of 
selection and condensation of amino acids [52-53]. Each elongation cycle in non-ribosomal 
peptide synthesis requires the cooperation of three domains which includes i) an adenylation 
domain ii) a thiolation or peptidyl carrier domain and iii) a condensation domain located be-




concluded that both the machineries of ribosomal and non-ribosomal peptide biosynthesis are 
similar, but are unique in its own respective features. The need for primary metabolism and 
several proofreading mechanisms in ribosomal synthesis of peptides are not needed in case of 
non-ribosomal peptide synthesis [54]. 
Only twenty standard amino acids make proteins, whereas the non-ribosomal peptide synthe-
sis uses a large range of substrates to produce wide varieties of peptides. It is possible because 
of the massive assembly line synthetases that produce these non-ribosomal peptides [55]. In 
NRPSs the arrangement and sequence of modules defines the fate of resulting peptides. The 
synthesized peptides are usually 3-15 amino acids long, while the maximum length is being 
imposed by the enormous size of NRPSs. They produce not only bigger molecules, but also 
structurally diverse NRP that exceed ribosomal production of peptides. This is mainly 
achieved by incorporating proteogenic, non-proteogenic amino acids, as well as β-hydroxy 
and carboxylic acids for their synthesis [56]. 
The enzymatic conversion of building blocks into their stereoisomer, heterocyclic rings, acyl-
ation, glycosylation, N-C-, and O-methylation are factors responsible for structural variability 
of NRP. NRP had been classified into three groups, linear NRP (type A), iterative NRP (type 
B), and nonlinear NRP (type C), according to their biosynthetic ability [55]. NRP often con-
tain high levels of hydrophobic residues. The incorporation of long chain fatty acids render 
the peptides more hydrophobic allowing them to diffuse easily out of the cell wall and other 
biological membranes. In general, most NRP has modified or unusual amino acids at C or N 
termini [54], making them resistant to cleavage by proteases and other destroying enzymes. 
Furthermore, the enormous structural diversity and peptide structures allow them to fit into a 
wide variety of targets. As a result, NRP is biologically active and structurally stable. Produc-
ers of nonribosomal peptides are mostly members of the Gram positive such as Actinomycetes 
and Bacilli genera. The filamentous fungi and marine microorganisms are also included in this 
list [18]. 
1.3.1 Modules and Domains 
NRPSs consist of an arrangement of modules. A module can be defined as a unit responsible 
for incorporating a building block into a growing polypeptide chain [50]. Modules are dis-




act as a template as well as a biosynthetic machinery for polypeptide synthesis. The catalytic 
sites residing in domains can perform various functions ranging from covalent binding, sub-
strate activation, and peptide bond formation of nonribosomal peptide synthesis [52]. Do-
mains with common functions share similar sequence, the so-called ‘signature sequences’ that 
can be used to predict cognate substrates of the newly identified NRPS. The change of selec-
tivity for substrates can be obtained using site-directed mutagenesis, which might serve as a 
powerful tool to obtain new products [55]. 
 
Figure 2: Genes involved in the synthesis of each module and domains. The module recruits a single amino acid 
into its pockets. Modules are dissected into domains that harbour catalytic activities for substrate activation (A-
domain), covalent loading and transport (CP-domain), and peptide bond formation (C-domain). 
1.3.2  Additional domains 
The NPRS contain enzymatic machineries and a big repository of enzymes which are in-
volved in peptide building up and processing of products [57]. The most common tailoring 
domains are Cy-domains and E-domains. Tailoring domains carry out their function as an 
integral part of NRPS acting in cis or trans to mature products [58]. 
The formation of a peptide bond takes place in a three step mechanism along with heterocy-




ozoline or oxazoline rings to the peptides which help them to intercalate or chelate with met-
als and thus adding important functional elements. [60]. 
The occurrence of D-amino acid is one of the striking features of nonribosomal peptide syn-
thesis. The incorporation of D-amino acids occurs via E-domains which are located at the C-
terminal end of modules. The enzyme catalyses the epimerization of the PCP-bound L-amino 
acid or C-terminal amino acid of the growing polypeptide chain [61]. The E-domain is a pep-
tidyl epimerase which determines the enantiomer of NRP [60]. 
A number of NRPS contains methyltransferase responsible for the methylation of N- and C- 
terminal amino acids, making the protein less susceptible to preoteolytic cleavage. N-MT is 
usually located between the corresponding A- and T-domains, and catalyzes the transfer of the 
methyl group from S-adenosyl methionine (SAM) to the α-amino group of the thiosterified 
amino acid. Glycosylation is also another important post processing modification for the func-
tionality of the peptide [62]. 
Posttranslational modifications of domains are essential for the functionality of NRPS [63-
64]. On this account, one of the main players of NRPS, the PCP domain has to be posttransla-
tionally modified in order to carry out its function as an active enzyme. Intermediate building 
blocks of NRP are tethered to this domain posttranslationally into the flexible arm. For this 
purpose, the 4’PP moiety of CoA is transferred to a conserved serine residue of the apo-CP 
which is converted into an active holo-CP [62]. The transfer of 4’PP is catalyzed by a PPTase 
in an Mg2+-dependent reaction. PCPs are sometimes erroneously acylated by PPTases using 
acyl-CoA instead of CoA as the 4’PP donor. The latter process of misacylation requires a 
deacylation step that is executed by type II thioesterases (TEIIs) [65]. 
1.4 Regulation in antibiotic genes 
The endospore forming bacterium B. subtilis is able to produce more than a dozen of antibiot-
ics. The antibiotics are secondary metabolites, produced under starving condition of nutrition-
al stress. The regulatory proteins that are involved in the regulation of antibiotic genes are 
produced during the early transition period to late stationary phase. The control mechanisms 




are regulating antibiotic production are discussed below. Most of these global regulators con-
trol antibiotic production either by direct or indirect regulation. 
1.4.1 Bacillomycin D regulation in Bacillus amyloliquefaciens FZB42 
B. amyloliquefaciens FZB42 is a potential synthesizer of several antimicrobial compounds 
which helps in warding away pathogens at rhizosphere [19]. Bacillomyin D is a lipopeptide of 
the iturin family synthesized nonribosomally by B. amyloliquefaciens FZB42 according to the 
multicarrier thiotemplate mechanism. It is synthesized during stationary phase. At the molecu-
lar level, the bmyD gene is transcribed through bmy operon. It consists of four genes (bmyD, 
bmyA, bmyB, bmyC) without orthologues in B. subtilis 168. 
The transcriptional regulatory mechanism of bacillomycin D biosynthesis has been elucidated 
by Koumoutsi et al. [66]. It was shown that bmy was dependent on a single σA dependent 
promoter favoured by a small regulatory protein DegQ. Furthermore, it has been shown that 
the global regulator DegU, YczE and ComA are essential for the full activation of the bmy 
promoter. 
1.4.2 Regulation of the srfA operon 
Surfactin is a cyclic lipopeptide produced by B. subtilis and other Bacillus species. Due to the 
amenability of Bacillus for genetic manipulation, it has been a subject of several studies. Sur-
factin-producing colonies are phenotypically identified by a zone of lysis on the erythrocyte 
agar medium. The Tn917 insertion mutations that are defective in surfactin were isolated and 
found to contain two loci originally called srfA and srfB (Nakano et al. 1988; 1992). 
The srfA is an operon consisting of 4 different genes. The orfi (srfAA) encodes the peptide 
synthetase subunit that functions in the incorporation of the constituent amino acids Glu, Leu, 
and D-Leu. orf2 (srfAB) encodes the subunit that catalyses the incorporation of Val, Asp, and 
D-Leu. orf3 (srfAC) functions in the incorporation of Leu, and orf4 (srfAD) encodes a protein 
with significant sequence similarity to that of the thioesterase-like product of grsT gene which 
is a member of the gramicidin S synthetase operon, grs. The transcription of srfA is dependent 




opment of competence. The production of surfactin is limited to Bacillus which has the ability 
to produce Sfp protein [69]. 
1.5 Bacilysin - a dipeptide 
Bacilysin is a dipeptide antibiotic. It consists of L-anticapsin and L-alanine. The name 
bacilysin was first given to an antibiotic produced by the strain of B. subtilis N.C.T.C. 7197, 
which was isolated from the soil at Oxford [70]. Despite its simple structure, it has an impres-
sive antimicrobial activity against a wide range of bacteria and some fungi [71]. The mode of 
its antimicrobial activity is mainly due to inhibition of the glucosamine synthesis, leading to 
defects in microbial cell wall [72-73]. It has been well established that prephenate, an inter-
mediate of the aromatic amino acid biosynthetic pathway, is the primary metabolic precursor 
of the anticapsin moiety of bacilysin [74-75]. Anticapsin is responsible for the antimicrobial 
activity of bacilysin. It is released from bacilysin on hydrolysis and transported into the cell 
[76]. 
 
Figure 3: Structure of bacilysin indicating N-terminal alanine and C-terminal anticapsin.  
The bacABCDE operon was shown to encompass the core biosynthetic genes of bacilysin 
production [77]. Besides these five genes, a monocistronic gene ywfH, is also essential for the 
complete cycle of bacilysin production [78]. The function of these genes has been proposed 
by C.T. Walsh et al. [75]. It was demonstrated that BacA and BacB are involved in converting 
prephenate into dihydro-4-hydroxyphenylpyruvate (H2HPP 4) and (H2HPP 5), respectively. 
The YwfH is involved in converting H2HPP 5 to H4HPP 6, making the precursor for anticap-
sin, whereas the function of BacC is unclear. The BacD and BacE were shown direct amino 




production of bacilysin under physiological conditions, it was demonstrated that a tempera-
ture of 25°C and pH 6.8 are suitable conditions for bacilysin production [79]. 
Regulation of bacilysin production has been the subject of study for a long time. In B. subtilis 
168, bacilysin production is controlled by a dual regulation system composed of the guanine 
nucleotides ppGpp and GTP sensed by CodY to mediate repression [78]. In additon, the com-
petence regulating gene products such as ComP-ComA, ThyA, YbgG, OppA, Spo0A and 
AbrB are shown to affect bacilysin production [80-81]. 
1.6 Organization of bac genes 
Most of the structural genes for bacilysin biosynthesis are organized in a single operon. The 
ywfABCDEFG was renamed as ywfA-bacABCDE-ywfG-ywfH [77]. The putative functions of 
each gene have been assigned. The function of ywfA , a monocistronic gene upstream of 
bacABCDE , is still unknown. Its putative function has been assigned to the major facilitator 
super family (MFS) class of proteins. This family also includes a wide range of uniporters, 
antiporters and symporters, helping in the transportation of secondary metabolites across cy-
toplasmic membrane. The first three genes determine the fate of anticapsin production, while 
the fourth gene, bacD, was shown to ligate amino acid, catalyzing peptide bond formation 
between L-Ala and anticapsin. The fifth gene, bacE, is involved in host resistance  
The putative functions of the first three genes have been proposed by Mahlstedt et al. (2010) 
based on bioinformatic analysis. BacA is homologous to prephenate dehydratases which are 
involved in decarboxylation of prephenate. BacB is a member of bicupin iron enzyme family. 
Finally, BacC is proposed to have nicotinamide-dependent reductase or dehydrogenase activi-
ty. Whereas, the function of ywfG, the sixth gene of bacilysin production is predicted to code 
for an aminotransferase, the gene next is the ywfH which has a putative nicotinamide-
dependent reductase activity (see Fig.4). However, Mahlstedt et al. have reported BacA, 
BacB, YwfH and YwfG to be involved in the synthesis of the nonproteinogenic amino acid, 






Figure 4: The pathway of bacilysin biosynthesis from prephenate was depicted as proposed by Mahlstedt et al. 
(2010). The function of each protein was described in the text. 
1.7 Research objectives 
B. amyloliquefaciens FZB42 is a strain harboring an enormous potential to synthesize a wide 
range of antimicrobial, antifungal and nematocidal compounds. Bacilysin is a dipeptide anti-
biotic having antimicrobial activity and it is synthesized by FZB42 during the exponential and 
transition phase. The main objectives of this research have been to establish the promoter of 
bacilysin, deciphering the transcriptional start point and identifying the major transcriptional 
regulators involved in the molecular mechanism of bacilysin production. 
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2 Materials and Methods 
The chemicals and instrumental materials used in this study are listed below. 
2.1 Chemicals and Materials 
Table 2: Chemicals used in this work. 
Manufacturer Products 
Fermentas Restriction enzymes, DNA markers, dNTPs, pres-
tained protein ladder, RevertAid M-MuLV reverse 
transcriptase (200 U/μl), RiboLock ribonuclease in-
hibitor (40 U/μl), T4 DNA ligase, T4 kinase, and T4 
polynucleotide kinase. 
USB Thermo Sequenase cycle Sequencing kit 
MP Biomedicals Urea pure 
Carl Roth Agarose NEEO (ultra-quality), chloramphenicol, 
citric acid, CuSO4, DEPC, FeCl2, FeCl3, Fe2(SO4)3, 
formaldehyde, L-glutamic acid, glycerol, HEPES, 
IPTG, KCl, K2HPO4, H2KPO4, maleic acid, MgSO4, 
MnCl2, MnSO4, Na-acetate, Na-citrate, Na2CO3, 
NaCl, NaOH, (NH4)2SO4, peptone, SDS, proteinase 
K, Rotiphorese Gel 40 (19:1), Rotiphorese Gel 40 
(29:1), TEMED, Tris, Triton-X 100, Tween 20, 
XGal, yeast extract, ZnCl2 
Roche Anti-DIG AP, Ampicillin, blocking reagent, DIG-
dUTP, kanamycin 
Macherey-Nagel Nitrocellulose membrane porablot NCL, Nucleo 
Spin ® Extract II, Nucleo Spin RNA L, Porablot NY 
plus, Protino® Ni-1000 kit 
Promega BCIP (50 mg/ml), NBT (50 mg/ml), pGEM-T® Vec-
tor systems 
Qiagen QIAEX II gel extraction kit, QIAprep Spin mini prep 
kit, Qiaquick PCR purification kit 
Bio-Rad Blotting grade blotter non-fat dry milk 
Hartmann Analytic [γ- 32P]ATP 
Fluka CaCl2, EDTA 
Santa Cruz Biot. His-probe H15 sc-803 rabbit polyclonal IgG (200 
mg/ml) 
Sigma Oligonucleotides, Anti-rabbit IgG AP 
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2.2 Bacterial strains, Plasmids and Primers  
All the bacterial strains, plasmids and primers used in this study are listed below as tables. 
2.2.1  Bacterial strains 
Table 3: Bacterial strains used in this study. 
Bacterial Strains  Genotype Reference 
B.amyloliquefaciens 
FZB42 
Wild type FZB 
RSO6 FZB42 ΔbacA::Cmr, 
Δsfp::Em r  
[82] 
AA1 AK13 Δ amyE::Pbac0-lacZ 
(Spec r) 
This study 
AA2 AK13 Δ amyE::Pbac892bp-
lacZ (Cm r) 
This study 
AA3 AK13 Δ amyE::Pbacbp335bp-
lacZ (Cm r) 
This study 
AA4 AK13 Δ amyE::Pbac305bp-
lacZ (Cmr) 
This study 
AA5 AK13 Δ amyE::Pbac257bp-
lacZ (Cm r) 
This study 
AA6 AK13 Δ amyE::PywfH540bp-
lacZ (Cm r) 
This study 
AA7  AK13 Δ amyE::PywfH600bp-
lacZ (Cm r) 
This study 
AM01 FZB42 ΔalsD::Spec r This study  
AM02 FZB42 ΔalsS::Cm r This study  
AM03 FZB42 ΔthyB::Cm r This study  
AM04 FZB42 ΔthyA::Spec r This study  
AM05 FZB42 ΔsigD::Spec r This study  
AM06 FZB42 ΔsigM::Km r This study  
AM07 FZB42 ΔabrB::Km r This study  
AM08 FZB42 ΔydjL::Spec r This study  
AM10 FZB42 Δhpr::Spec r This study  
AM11 AA2 ΔcomA ::Em r This study  
AM12 AA2 ΔdegU ::Em r This study  
AM13 AA2 Δhpr ::Em r This study  
AM14 AA6 ΔdegU ::Em r This study  
AM15 AA7 ΔabrB ::Em r This study  
AK38 E. coli DH5α pREP4 
pAK54 
[66] 
CH23 FZB42 ∆comA::Em r  X.-H. Chen, un-
published 
TF1 FZB42 ∆degU::Em r T.-F. Huang, un-




AK57 Derivat FZB42 ΔsigB::Emr 
ΔrapX::Cmr 
Laboratory stock 
AK48 Derivate FZB42 ∆sigX::kmr  Laboratory stock 
CH30 FZB42 sigV::Em r X.-H.Chen 
 
2.2.2 Plasmids 
Table 4: Plasmids used in this study. 
Plasmid/Reference Description  Reference 







pAFN0 pAK9 carrying a frag-
ment of bacA from -400 
to +126 bp  
This study 
pAFN1 pAK9 carrying a frag-
ment of bacA from -400 
to +126 bp  
This study 
pAFN2 pAK9 carrying a frag-
ment of bacA from -400 
to +126 bp  
This study 
pAFN3 pAK9 carrying a frag-
ment of bacA from -400 
to +126 bp  
This study 
pAFN4 pAK9 carrying a frag-
ment of bacA from -400 
to +126 bp  
This study 
pAFN5 pAK9 carrying a frag-
ment of bacA from -400 
to +126 bp  
This study 
pAYN1 pAK9 carrying a frag-
ment of ywfH from -400 
to +126 bp  
This study 
pAHN1 pAK9 carrying a frag-
ment of hpr from -400 to 
+126 bp  
This study 
pAM01 pGEM-T carrying 
alsD::spec r 
This study 
pAM02 pGEM-T carrying 
alsS::Cm r 
This study 
pAM03 pGEM-T carrying This study 




pAM04 pGEM-T carrying 
thyA::Specr 
This study 
pAM05 pGEM-T carrying 
sigD::Spec r 
This study 
pAM06  pGEM-T carrying 
sigM::Kmr 
This study 
pAM07 pGEM-T carrying 
abrB::Kmr 
This study 
pAM08 pGEM-T carrying 
ydjL::Specr 
This study 










Sequence (5' to 3' end)/ Restriction sites* Use 
alsSfp TTATTCCGGGCTTCCTTCG AM02 
alsSrp CGGCAACGGCAATAAAGTATT AM02 
alsDfp TGACTCTTATCTCGTTTCCGC AM01 
alsDrp ATGAGCCGCTGAAACTGTTGAT AM01 
SigD fw TTAGCAGGTTCCTATTTAACGG AM05 













ThyA fw TTCATTCCGCCATTCGTCATGTC AM03 










AbrB Rrw- ATAATAGGGCCCATCAAGCGCCATCAGCATAATCG AM07 




Hpr FW TGAAATAACCGCATACCGAAACC AM10 
Hpr RW TCGGATTCCTGGTCAATCAGAC AM10 
ThyB fw AAGGTTCCGTATCATCACGC AM04 
ThyB rw ATGTGCGGATATTACACGCTCATCCAGTCAGG AM04 
Amyback1fw AAGAGTCCACATGGATGAGTG AA1 
Amyfront2fw TACAGCCATTCAGACATCTCC AA1 
LacZfw ACCAGACCAACTGGTAATGG AA1 









HindIII   
ATTAAAGCTTAAATGTTAATTTTAACACCC AA3 
AkBacN4Fw 
HindIII   
TTATTAAGCTTTGTTTTCTAATATATAGG AA4 
AkBacN5Fw 
HindIII   
TTTATAAGCTTTGACAGCTTGAACATCTATG AA5 
bacFP1a   ATGAGCATCAGGCCGACCAAAC FP/EMSA 
bacFP1b  ATCCATAGATGTTCAAGCTGTC FP 
bacFP2a TCATAGGGTGTTTTCTAATATATAG FP 
bacFP2b TTAAGTAAATATTATCCATAGATG FP 
bacFP3a TTCAAATAATATTGACAGCTTG FP 






BacFp1aRW ATTCCTATATATTAGAAAAC FP 
Hpr FPF1 GGAGGAAATCAAACCGCACC FP/EMSA 
Hpr FPF2 CCTCTATTATGCCAATAAAATAAAG FP/EMSA 
Hpr FPF3 TATTTTATTGGCATAATAGAGG FP/EMSA 









YwfH PE 2 ATAATAAACGCGGTTCGTTTTGAC PE 
Hpr PE 2 AAGGCGGTTCAACACGATTC PE 
ywfH-hindIII ATATATAAGCTTAGCGATGATGTGCTTCAGTTC AA6 
ywfH-SalI ATATTGTCGACTTCTTTCCATAGGTTTCCGACG AA6 
ywfH FW FP TCGACACGCTTCCGAAGTTTTTG FP 
ywfH RW FP ACGCGGTTCGTTTTGACAACTG FP 
Spec Fw CTCAGTGGAACGAAAACTCACG AM10 
Spec Rw TAAGGTGGATACACATCTTGTC AM10 
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FP-primers used for footprint, EMSA. PE-Primer extension, restriction sites used are under-
lined. 
2.2.4  Media and supplements 
Table 6: All media were prepared and sterilized according to the standard procedure. 
Media  Ingredients  
GA medium  7 g/l K2HPO4, 2 g/l KH2PO4, 0.1 g/l 
MgSO4, 1 g/l (NH4)2SO4, 0.05 g/l Yeast 
extract, 0.15 mg/l Fe2(SO4)3 x 6H2O, 5 
mg/l MnSO4.H20, 0.16 mg/l CuSO4.x  
,5H2O, 13 g/l sucrose. 
LB Medium  1 % w/v Peptone, 0.5 % w/v yeast ex-
tract, 
0.5% w/v NaCl 
Antibiotics  
Amplicillin 100 μg/ml 
Chloramphenicol 20 μg/ml (for E. coli), 5 μg/ml (for 
Bacilli) 
Erythromycin 1 μg/ml (for Bacilli) 
IPTG 1 mM 
Kanamycin 20 μg/ml (for E. coli), 5 μg/ml (for 
Bacilli) 
Lincomycin 25 μg/ml (for Bacilli) 
Xgal 40 μg/ml 
 
2.2.5 Buffers 
Table 7: All the buffers used in this study. 
Buffers Ingredient 
Transformation buffer 
MDCH 1X PC buffer, 0.1 M Glucose, 0.005 % 
tryptophan, 0.04 M FeCl3/Na-citrate, 3 
mM MgSO4, 0.5 % w/v Na-glutamate, 
0.1 % casein hydrolysate. 
MD 1X PC buffer, 0.1 M glucose, 0.005 % 
tryptophan, 0.04 M FeCl3/Na-citrate, 3  




10X PC 0.8 M K2HPO4, 0.45 M K2HPO4, 0.028 
M Na-citrate 
 Transformation buffer 1X SMM, 1 mM EGTA, 0.025 M glu-
cose, 0.02 M MgCl2 
Southern Blot 
Denaturation buffer 1.5 M NaCl. 0.5 M NaOH 
Neutralization buffer 1.5 M NaCl, 1 M TrisHCl pH 8.0 
Hybridisation buffer  5X SSC, 1 % blocking reagent, 0.1 % 
N-laurylsarcosin 
P1-Dig buffer 1 M Maleic acid (pH 7.0), 5 M NaCl, 1 
% w/v blocking reagent 
Wash buffer 0.1 M Maleic acid, 0.1 % NaCl, 0.3 % 
v/v Tween20 
Ap buffer 0.1 M TrisHCl, 0.05 M MgCl2, 0.1 M 
NaCl  
ß-Galactosidase 
Z-buffer 100 mM Na-P-buffer pH 7.0, 10 mM 
KCl, 1 mM MgSO4.7H2O, 1 mM DTT, 
0.3 mg/ml lysozyme, 100 µg/ml chlo-
ramphenicol, 0.005 % Triton X100, 0.5 
U/ml benzonuclease  
ONPG 4 mg/ml in Z-buffer 
Stop solution 1M NaCO3 
SDS-PAGE 
Storage buffer 50 mM TrisHCl pH 8.0, 0.5 mM 
EDTA, 100 mM NaCl , 0.5 mM DTT, 
50 % glycerol 
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1X SDS-loading buffer 100 ml 10X Laufpuffer, 10 ml 10 % 
SDS make up to 1L with dH20 
10X TBS 100 mM TrisHCl (pH 8), 1.5 M NaCl 
10X loading buffer 0.25 M TrisHCl (pH 8.3) , 1.92 M 
glycin 
Fixing solution 1 Vol.acetic acid (100 %), 1.Vol.EtOH 
(96 %), 5.vol.dH2O 
Protein staining solution 0.2 % Coomassie R 250, 0.05 % Coo-
massie G250, 42.5 ethanol, 10 % acetic 
acid, 5 % methanol 
RNA Preparation   
Killing buffer 20 mM TrisHCl pH7.5, 5 mM MgCl2, 
20 mM NaN3 
10X MEN 200 mM MOPS, 50 mM Na-acetate,  
10 mM EDTA pH 7.0 
EMSA buffers 
5X Binding buffer 100 mM TrisHCl pH8.0, 500 mM KCl 
25 mM MgCl2 2.5 mM DTT, 50 % 
glycerol, 0.25 Nonidet P40, 0.025 w/v 
polydI-dC, 0.025 w/v BSA 
6 % 7 M urea polyacrylamide gel 25 g urea, 6 ml 10X TBE, 9.2 ml 
AA/BAA (19:1) to 60 ml with dH2O 
10X TBE 121.1 g/l Tris Base, 51.3 g/l boric acid, 
3.72 g/l EDTA 
Foot print buffers 
DNase I – Stop solution 0.4 M Na-Acetate, 50 µg/ml Calf 
Thymus DNA 
Stop solution 95 % deionised formamide, 20 mM 
EDTA pH 8.0, 0.05 % bromophenol 
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blue, 0.05 % xylencyanol 
Other buffers 
Sodium phosphate buffer 1 M Na2HPO4/NaH2PO4 
Phosphate buffer 1 M KH2PO4/ K2HPO4 
10X TE  100 mM TrisHCl (pH 7.5), 10 mM 
EDTA (pH 8) 
 
2.3 Methods  
2.3.1  Bacterial transformation  
Competent cells of B. amyloliquefaciens FZB42 were obtained as previously described [83]. 
Cells were grown overnight in LB medium at 28°C (170 rpm). The next day, they were dilut-
ed in glucose-casein hydrolysate-potassium phosphate (GCHE) buffer to an OD600 of 0.3. The 
cell culture was then incubated at 37°C under vigorous shaking (200 rpm) until the middle of 
exponential growth (OD600 ~1.2). Dilution with an equal volume of GC medium followed and 
the cells were further incubated under the same conditions for 1 hour. Further on, the culture 
was divided in 2 ml Eppendorf tubes and cells were harvested by centrifugation at 6000 rpm 
for 5 min (room temperature). The pellets were resuspended in 100 μl of the supernatant and 
the desired DNA (1 μg) with 2 ml transformation buffer was added to them. After incubation 
at 37°C under shaking at 75 rpm for 20 min, 1 ml LB medium containing sublethal concentra-
tion (0.1 μg/ml) of the appropriate antibiotic was added. The cells were grown under vigorous 
shaking for 90 min and platted on selective agar plates. 
2.3.2 Antibiotic sensitivity test (AST) and bioautography 
For the antibacterial tests, B. amyloliquefaciens FZB42 and its derivatives were grown and 
treated in the same manner. The indicator strain was grown overnight at 37°C under vigorous 
shaking. The indicator plates were prepared by mixing 1 ml of the culture to 3 ml soft agar 
and poured onto petri dishes. Supernatants obtained from the B. amyloliquefaciens FZB42 
strains, grown in GA medium for 24 hours, were applied to the plates and incubated at 37°C. 
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Bioautography of bacilysin was performed essentially as previously described (Chen et al., 
2006). Samples were collected from the supernatant of cultures grown in GA medium. 20 µl 
of the samples were loaded onto thin-layer chromatography (TLC) aluminum sheets (20 by 20 
cm; Merck, Darmstadt, Germany), for B. megaterium bioautography.TLC was performed us-
ing a mobile phase consisting of 1-butanol/acetic acid/water 4:1:1 (v/v/v). The TLC plate was 
cut into strips. The strips containing spots were placed onto the solid GA medium containing 
the indicator strain. Strips were allowed to stay on the agar for 30 - 60 min and removed. 
Plates were incubated at 30o. 
2.3.3 Southern blot 
Southern blotting involves transfer of DNA molecules from an agarose gel onto a membrane. 
It is designed to locate a specific sequence of DNA in a complex mixture. The shorter the 
probe, the more specific is the detection. For Southern hybridization, an appropriate probe 
was PCR labelled with digoxigenin-11-dUTP (DIG-dUTP), according to the Ready-to-Go kit 
from Roche. The DNA region was amplified with specific primers. ( DNA 50 ng, dNTP(2 
mM), 1 mM Dig-11-dUTP, 0.1 units of Tag to a final volume of 50 µl). The labelled product 
was then stored at -20°C until use. 
1-2 μg of the chromosomal DNA of FZB42 were digested overnight with a suitable restriction 
endonuclease. Samples were initially separated on a 0.8 % agarose gel in 1 x TAE buffer at 70 
Volt. The gel was washed twice with denaturation buffer and subsequently with neutralization 
buffer for 20 minutes. ssDNA was transferred onto a positivated nylon membrane with the 
pore size of 0.45 µM. It has a binding capacity of about 500 µg/cm. Transfer on the nylon 
membrane was performed using the Bio-Rad vacuum blotter (model 785). The DNA was 
cross-linked to the membrane using UV radiation. 
Hybridisation and detection The membrane was initially incubated for 1 hour at 65°C with 
40 ml hybridization buffer and was hybridized overnight at 55°C with 5-10 ml hybridization 
buffer containing 5-25 ng/ml of denaturated DIG-labelled probes. The membrane was washed 
twice for 15 minutes, first with 2 x SSC/0.1 % SDS at room temperature and again with a 
lower amount of SSC ( 0.5 x SSC/0.1 % SDS at 55°C). 
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Detection was achieved by a colorimetric approach. The membrane was first equilibrated with 
P1-DIG buffer and was then incubated for 30 minutes with P1-DIG buffer containing 3.75 
units of the antibody Anti-Digoxigenin-Alkaline-Phosphatase. Unbound antibody was re-
moved after a fifteen minute washing step. The 10 ml AP buffer containing 2.25 mg nitroblue 
tetrazolium salt (NBT) and 1.75 mg 5-bromo-4-chloro-3-indolyl phosphate (BCIP) was added 
to the membrane in a petri dish and incubated in the dark allowing visualization of the hybrid-
ized DNA with our labelled probe. 
2.3.4 HPLC and HPLC-MS assay of bacilysin  
High pressure liquid chromatography was performed with the HPLC 1100 device from HP 
Agilent, Waldbronn, Germany, essentially as previously described (Schneider et al., 2007). In 
brief, 10 µl sample was injected onto a HPLC column (Luna® 5 µm C18 (2) 100 Å LC col-
umn 100 x 4.6 mm). The temperature was kept at 30◦C during the experiment. The run was 
performed with a flow rate of 1.5ml/min and a gradient of solvents A (H20 + 0.1%, HCOOH) 
and B (CH3CN + 0.1 % HCOOH), which reached 100 % B after 12 min. To equilibrate the 
column, it was treated with 5 % CH3CN–HCOOH for 3 min. A diode-array detector in the 
range from 190 nm to 550 nm was used for detecting peaks. Bacilysin was detected at 230 
nm. 
 
HPLC- MS of bacilysin was performed on an Exactive Orbitrap system (Thermo Fisher Sci-
entific, Bonn, Germany) coupled with an Agilent 1100 HPLC system (Agilent, Waldbronn, 
Germany). Aliquots of the culture filtrates of wild-type and mutant strains were fractionated 
by reversed-phase HPLC on a Zorbax Eclipse Plus C18, Rapid Resolution HD (2.1 x 50 mm, 
1.8-Micron from Agilent) at a flow rate of 1.5 ml/min with a gradient of 5 % CH3CN plus 
0.1% formic acid to 100% CH3CN plus 0.1% formic acid in 8 min and further to 5 % CH3CN 
plus 0.1% formic acid in 10 min. Every sample was measured in the negative and positive 
mode, and mass spectra were acquired in an m/z range of 50 to 500 at a scan rate of 1,000 
atomic mass units/s. 
 
2.3.5 Quantification of specific β-galactosidase enzymatic activity 
Specific β-galactosidase activity was determined from growing liquid cultures in GA medium, 
according to [84]. At different times of the growth curve the optical density of the culture at 
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600nm was determined and cells were harvested. Their pellets were frozen in order to be fur-
ther used in the β-galactosidase assay. 
Pellets were resuspended in 800 μl Z-buffer. After short vortexing, they were incubated on ice 
for 10min and at 30°C for 10 min. The reaction began by addition of 200 μl ortho-
nitrophenyl-β-D-galactopyranoside (ONPG) 4 mg/ml at 30°C and was stopped by addition of 
400 μl 1 M Na2CO3, when their colour changed to yellow. The samples were then centrifuged 
for 5 min and the supernatant’s absorbance was measured at 420 and 550 nm. Specific β-
galactosidase activity was calculated in Miller units (MU) [85]. 
 ) 600 OD x V(t x  / ) 550 OD x 1,75 - 420 (OD x 1000 = (MU) unitsMiller  
According to the formula, 
OD420, OD500, OD600 = Optical density at 420,550 and 600nm 
t = reaction time (min) 
V = volume of the sample of bacterial cells used for the reaction (ml) 
 
2.3.6  Overexpression and purification of His-tagged DegU and Hpr 
The DegU protein was prepared similar to previous work [66]. Strain AK38 was grown over-
night at 37°C in LB medium containing 100 μg/ml ampicillin and 20 μg/ml kanamycin. The 
culture was diluted in 500 ml LB-Ap/Km to an OD600 of 0.03 and was further grown at 30°C 
under vigorous shaking. When the cells had grown to an OD600 of 1, ethanol was added to a 
final concentration of 3 % to induce chaperone synthesis and minimize formation of inclusion 
bodies. After 15 minutes, IPTG was added to the cultures at 1 mM final concentration. The 
cultures were grown for 2.5 hours and were then centrifuged at 6000 rpm for 20 minutes. The 
pellets were stored at -80°C. The protein was then purified with the Protino® Ni-1000 kit ac-
cording to the manufacturer’s instructions (Macherey Nagel) and was subsequently dialysed 
overnight against storage buffer at 4°C. 
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Hpr protein was overexpressed by amplifying a fragment using the primers Hpr2Fw NdeI/ 
Hpr2Rw BamHI and cloned into pET 15b (Novagen) vector which carries an N-terminal His 
Tag (see primers in Table 2.2.3). The overexpression was performed by growing E. coli BL21 
(DE3) harbouring pET 15b-hpr overnight in LB lactose (1 % final concentration) in the medi-
um. Subsequently, the purification was performed using the Protino Ni-1000 kit, according to 
the manufacturer’s instructions (Macherey Nagel). 
2.3.7 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis was performed according 
to [86]. The proteins in the gel were separated using the “Mini-Protean II” apparatus of Bio-
Rad. Gels were run at 200 Volt in 1 x SDS running buffer and were stained with protein stain-
ing solution (see buffers section). 
2.3.8 Urea gel 
The gel was left to prerun before loading the samples for 1 hour at 60 Watt in 1x TBE buffer, 
using the SequinGen Sequencing Cell of Bio-Rad. After loading the samples, DNA separation 
was performed for approximately 100 minutes more using the same running conditions. The 
gel was dried at 80°C for 1 hour using the vacuum SlaB Gel Dryer Model SE1160. An IP 
screen was put on the top of the dried gel and visualization was achieved using the Molecular 
Imager FX scanner (Bio-Rad). 
2.3.9  Radiolabelling of primers 
Primers were radiolabelled using the T4 polynucleotide kinase (PNK). PNK catalyses the re-
actions at the 5’-OH end by transferring of the γ-phosphate from 32P- ATP. The reaction was 
carried out with 40 pmol of primer and 4 μl of [γ-32P] ATP (10μCi/ml). The reaction mixture 
was incubated at 37 °C for 1 hour and heat inactivated at 70°C for 10 minutes. 
2.3.10  Sequencing of radioactive DNA 
Sequencing reactions were carried out using the Thermo sequenase cycle Sequencing kit 
(USB) according to the manufacturer’s instructions. 100 ng of PCR fragment containing the 
desired fragment and 1 pmol of the radioactive primer were included in the reaction. Amplifi-
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cation was performed using a 23 cycle PCR pro [Tden=94°C (30 sec), Tanneal=58°C (sec), 
Text=72°C (30 sec)] 
2.3.11  RNA preparation 
Transition-phase cells of B. amyloliquefaciens FZB42 were harvested for preparation of total 
RNA.10 ml of the culture was mixed with 5 ml “killing” buffer (stops mRNA production and 
nucleases) and centrifuged for 10 minutes at 4°C and 12000 rpm. The pellet was washed with 
1 ml “killing” buffer and stored at -80°C. 
Isolation of RNA was performed using the Nucleo Spin RNA L (Macherey Nagel). In order to 
remove possible DNA contaminations, the isolated RNA was additionally extracted with an 
acidic phenol: chloroform: isoamylalcohol (25:24:1) mixture and then chloroform - ethanol 
precipitation followed .The pellet was resuspended in 20 μl DEPC-H2O. The concentration of 
total RNA was spectrophotometrically determined according to [1], whereas its quality was 
checked on a 1.5 % RNA agarose gel under denaturating conditions (1x MEN, 16 % formal-
dehyde) (For MEN see Table 2.2.5). The samples were mixed with 1.6 volume loading buffer 
and were incubated at 65°C for 5 minutes prior to loading on the gel. The gel was run in 1 x 
MEN buffer at 60 Volt. 
2.3.12 Primer extension  
Primer extension was used to map the 5' termini of mRNAs. 40 μg of total RNA was mixed 
with 0.15 μM radioactively (32P) labelled primer at 70°C for 5 minutes to anneal. Then 4 μl 5 
x reverse transcriptase buffer, 2 μl dNTPS (10 mM each) and 1 μl ribonuclease inhibitor (40 
units) were added to a final volume of 19 μl. After incubation at 37°C for 5 minutes, 1 μl re-
verse transcriptase (200 units) was added to the mixture and further incubation was allowed 
for 1 hour at 42°C. The primers used for identifying the transcriptional start of the bacilsysin 
operon are given in the table 2.2.3. 
2.3.13 Gel retardation assay 
Gel retardation assay or electrophoretic mobility shift assay (EMSA) is a common technique 
used to characterize protein-DNA/RNA interactions. In my case, the desired DNA fragment of 
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the bacA promoter region was amplified by PCR using primers bacFP1a and bacFP3b (Table 
2.2.3), one of which was previously labelled at its 5'-end with [γ-32P] ATP. The radio-labelled 
product (264 bp) was purified with the Qiagen PCR purification kit. After dilution of the la-
belled DNA fragment to attain final activity of 20.000 cpm, the DNA was incubated at 37°C 
for 30 minutes with increasing concentrations of DegU protein in the 1x binding buffer. The 
reaction mixtures were separated on 8 % polyacrylamide gels under non-denaturating condi-
tions in 1 x TBE buffer at 60 V. The gels were visualized using the Bio-Rad Molecular Imager 
FX scanner. 
Similarly, the EMSA for pywfH and pHpr was performed with the fragment synthesized using 
the primers ywfH FWFP, ywfH RWFP and hpr FPF1, hpr FPF4, respectively (Table 2.2.3). 
2.3.14 DNase I footprinting 
DNase I footprinting experiments were performed as described previously [87]. A DNA frag-
ment carrying the extended version of the bacA promoter (271 bp) was obtained by PCR am-
plification using primers bacFP1a and bacFP3b. It was incubated in binding buffer with dif-
ferent amounts of DegU protein (0, 1, 2, 5 and 10 µM) for 30 min at 37°C. Complexes were 
then treated with DNase I for 1 min, and the reaction was stopped by addition of DNase I stop 
solution containing non-specific calf-thymus-DNA (50 mg/ml). The treated complex was ex-
tracted using 95 % ethanol and dried at 50°C. Once the sample was completely dried, it was 
resuspended in 5 µl of stop solution. The samples were then separated on 7 M urea - 7 % pol-
yacrylamide sequencing gels and visualized using the Molecular Imager FX Pro Plus (Bio-
rad). 
For deciphering DegU binding on ywfH promoter, a DNA fragment containing 150 bp was 
PCR amplified using primers ywfH FW- FP and ywfH RW- FP. DegU protein of different 
amounts (0, 0.75, 1, 2, and 5 µM) was incubated for 30 min at 37°C. The rest of the procedure 
was performed as described for the bacA promoter. Similarly, a DNA fragment containing all 
of Hpr putative sites was PCR amplified (180bp; obtained using primers bacFP2a and 
bacFP3b) and incubated with different concentrations of Hpr protein (0, 1, 2, 4, and 8 µM) for 




3 Results  
3.1 Growth pattern of B. amyloliquefaciens FZB42 in GA medium 
Bacilysin, a dipeptide (L-alanyl-[2, 3-epoxycyclohexanone-4]-L-alanine) is composed of non-
proteogenic L-anticapsin at the C-terminus and L-alanine at the N-terminus. It is produced by 
B. amyloliquefaciens FZB42 during vegetative and transition growth stages. It is synthesized 
in a non-ribosomal fashion, however, it is independent of sfp which is required for multi-
modular NRPS [82]. In order to understand the nature of growth pattern, FZB42 was grown in 
GA medium developed by Scholz et al. [82]. It is a minimal media containing glucose and 
ammonium sulphate as carbon and nitrogen source, respectively. The production of bacilysin 
was found to peak at 30oC (170 rpm) and pH 6.5. The Figure 5 indicates the growth pattern of 
FZB42 in GA medium. 
 
 
Figure 5: Growth curve of FZB42 (wild type) which was grown in GA medium at 30oC. 
3.1.1 Antibiotic sensitivity test (AST) 
Studying the antibiotic activity of bacilysin, the antibiotic sensitivity test or the agar diffusion 
test was used to get information about the anti-bacterial activity. B. megaterium was used as 
indicator strain. To understand the regulation of bacilysin production, I used the inhibition-test 
with different deletion mutants such as TF1 (∆degU), CH23 (∆comA), AM10 (∆hpr), RS06 




biotics can inhibit the growth of B. megaterium, a sfp-deletion mutant was used as positive 
control. RS06, where ∆sfp and ∆bacA were knocked out, was used as negative control. 
 
Figure 6: Agar diffusion test indicates the antibiotic activity of bacilysin on B. megaterium. Different mutants 
showed different activity. The hpr mutant indicated highest activity, whereas degU and comA had a similar or 
less effect compared to wild type. RS06 (∆sfp and bacA) was used as negative control. CH3 (∆sfp) used a posi-
tive control.  
Comparing the results, CH3 (1.8 cm) had a smaller inhibition zone than wild type (2.5). Here, 
I have shown that comA and degU mutants had a smaller inhibition zone (2.1 and 1.9 cm re-
spectively) compared to the wild type. On the other hand, hpr mutant had a larger zone of 
inhibition (3.0 cm). The result indicated the possible regulators which might be involved in 
the gene expression of bacilysin biosynthesis  
3.1.2 Bioautography of bacilysin 
Bioautography was performed essentially as described in Chen et al. [82]. Cultures were 
grown to OD600 nm of 0.8-1.0. Supernatant was spotted directly on precoated TLC plates. 20 
µl of samples were loaded onto the plates which were placed in a chamber containing mobile 
phase solvents (1-butanol/ acetic acid/ water in 4:1:1 (v/v/v)). The gel was run for 2 hrs and 
thereafter it was dried at room temperature for an hour or more. Then the plate was stripped 




cator strains were prepared (see Materials and Methods). The strips were incubated on the 
plates for 30 min. Later, they were incubated at 37oC overnight.  
 
 
Figure 7: Bioautography of bacilysin was performed using B. megaterium as indicator strain. The second zone 
of clearance is the position of bacilysin. Both degU and comA mutants indicated lower production of bacilysin. 
RS06 is a double mutant of bacA gene and sfp gene, whereas CH3 is a mutant lacking sfp. They were used as 
negative and positive control, respectively. 
The results of TLC indicated production of bacilysin by different mutants and by wild type. 
The second zone of clearance in the bioautography indicates the position of bacilysin (see 
Fig.7). The obtained results show that degU and comA mutants affected the production of 






3.1.3 HPLC of bacilysin production in FZB42 
High performance liquid chromatography was performed with a C18 column (see Materials 
and Methods). Cell culture supernatant was used immediately after spinning down the cell 
debris. Bacilysin appeared early in the run (4.9 min) and it is highly hydrophilic. Therefore, it 
was not retained on the column. There are several other compounds in the chromatogram 
which could be metabolic remnants and medium components. Due to the unavailability of a 
standard, the bacilysin peak was identified by comparison with the chromatogram of non-
producing mutants (see Figure 25) and with an earlier work by Scholz et al. [82]. 
 
Figure 8: HPLC of bacilysin. Cell culture supernatant was used directly to measure bacilysin at 210nm. It ap-
peared at 4.9 min which is indicated by an arrow. 
 
3.2 Identifying the transcriptional start point of bacA and ywfH promoters 
The transcriptional initiation site (TIS) of the bac promoter was determined. Total RNA was 
extracted from B. amyloliquefaciens FZB42 from culture growing in GA medium. The sample 
was collected during vegetative growth phase of FZB42 (see Materials and Methods). Primer 
extension was used to identify the adenine (A) as +1 which is the start point of transcription 
for bac promoter. The upstream region of the mapped transcriptional start site confirmed the 
presence of consensus regions -10 (TAATAT) and -35 (TTGACA) for sigma factor σA. The 
well conserved elements of sigma A indicated that the substance is produced during 
vegetative growth of FZB42, whereas most of secondary metabolites are produced during 
stationary phase. The spacer between the -35 and -10 region is 18 bp long and has a well 




sequences [88]. It has well conserved promoter elements and a unique ribosomal binding site 
(TGGTTGGT) instead of conserved AGGAGGT. At this level, we propose that FZB42 
utilizes this less conserved RBS to avoid expression of bac genes all the time avoiding the 
energy expensive process of synthesizing and transport. 
 
Figure 9: The primer extension of pbac and pywfH is indicated above. A) The transcriptional start of pbac was iden-
tified as +1 which is an adenine. 1, 2 and 3 (1, 2 and 3 µl of 2 µM primer) represent different concentrations of 
primer used to obtain the transcriptional start point. B) Similarly, adenine was identified as +1 of the transcrip-
tional start of pywfH which is marked by a black arrow. 
The transcriptional start of pywfH was determined by primer extension. The start point was 
seen as single strong band which is more pronounced than bacA (see Fig.9). Interestingly, the 
start points of both pywfH and pbac are similar being an adenine base. Unlike the promoter of 
bacA, pywfH has not well conserved elements of promoter like -35 (TTAAAT) and -10 
(TCATTT) region. In this promoter, the ribosome binding site (AAGGAGA) is quite con-





3.3 Transcriptional regulation of bacilysin production in Bacillus amyloliquefaciens 
FZB42 
Bacilysin is produced during the exponential and transitional growth phase which was shown 
in an earlier part of this section [89]. Despite its small size, it is tightly regulated by transcrip-
tional regulators. It was found in this study that bacilysin is regulated by global regulators 
such as DegU (degradative and protease regulator) and Hpr, while ComA, CodY and AbrB 
are indirectly controlling the expression [90]. The presence of these regulators is essential for 
positive or negative regulation of bacilysin genes [78]. In this work, the promoters of bacA 
and ywfH genes were studied which are responsible for the biosynthesis of bacilysin. The 
promoter of the Hpr was also investigated and found to be regulated by AbrB, a global regula-
tor affecting gene expression.  
3.3.1 Promoter analysis of bacA (pbac) and ywfH (pywfH) 
The promoter of bacA and ywfH has been analysed in order to understand their role in expres-
sion of bacilysin genes. Several molecular techniques were employed to understand their 
mechanism of action. The bac operon was considered to be the major player in bacilysin pro-
duction; later it was reported that ywfH, a monocistronic gene, is also essential in the produc-
tion of bacilysin. Walsh et al. reported the function of YwfH to be an enzyme involved in 
converting intermediate substrate into pro-anticapsin moiety, which is a major part of the di-
peptide [75]. The Figure 10 shows the complete operon of bac genes and the monocistronic 
gene ywfH. 
 
Figure 10: The bac operon and the monocistronic gene, ywfH, responsible for bacilysin biosynthesis. 
The synthesis of bacilysin starts from prephenate of the aromatic amino acid pathway [91]. 
The function of each gene in the operon has been assigned bioinformatically, the first three 




which is critical for the functionality of bacilysin [77]. The rest of the genes is involved in 
amino acid ligase and imposesw self-immunity to the producer [78, 92]. 
The sections below will reveal the results of different molecular studies used to decipher the 
promoter and regulators of bacilysin. 
3.3.2 β-Galactosidase activity of bacA and ywfH promoters in wild type 
In order to determine the in vivo expression of the putative bacA promoter (upstream region of 
the first gene of bac operon), five reporter fusions were constructed using lacZ with common 
downstream ends and variable upstream ends. A series of four nested fragments was generated 
using the polymerase chain reaction (PCR) with help of primers AFN1 to AFN5 (see Table 
2.2.3). The generated fragments contain 5’-end deletions of bac promoter along with re-
striction sites, which can later be inserted into the vector PAK9. The vector was then integrat-
ed at the amyE locus of B. amyloliquefaciens FZB42. The correct chromosomal integration 
was confirmed using chromosomal PCR. The newly constructed strains containing variable 
lengths of promoter fused to lacZ were named as AA1, AA2 (-671 to +221bp), AA3 (-114 to 
+221bp), AA4 (-82 to +221bp), and AA5 (-36 to+221bp). The AA1 strain represents the con-
struct without promoter fragment which is prepared to facilitate the transformation of FZB42 
(see Fig.11). 
 
Figure 11: Schematic representation of different fragments used in lacZ fusion. 
The expression of the pbac promoter under in vivo conditions was assayed by the β-
galactosidase activity. The expression pattern was studied for the complete growth cycle of 
FBZ42. The activity starts after four hours of growth indicating its expression during the ex-





Figure 12: 5’deletion of pbac. Different constructs were grown in GA medium and their β-galactosidase activity 
was determined. The activity decreased, while the fragment size was reduced from 5’of the promoter end. AA5 
was the strain harbouring a fragment with deleted regions of essential promoter elements like -35 and -10 indi-
cating less or no activity. 
AA2 is the strain harboring the entire promoter region of pbac. The activity of AA2 reached the 
maximum after 10 hour concurrent with a published report for the production of bacilysin 
during transition growth stage [79]. The activity of AA3 got reduced compared to AA2. In this 
case, a part of the putative binding site of DegU (Identified through in silico analysis) was 
removed. AA4 exhibited much lower activity (~80 %) than AA2 (see Fig.12). AA4 contains 
the deleted version of two putative DegU binding sites. Furthermore, AA5 strain which has an 
extended region of deletions removing the -35 region had a deleterious effect on the expres-
sion of transcripts and remains silent during the entire growth cycle. In conclusion, the exper-
iments indicate that the selected gene region harbours the bacilysin promoter. 
3.3.3 β-Galactosidase activity of bacA and ywfH promoters in regulatory mutants 
The expression of bacilysin was studied in regulatory mutants of B. amyloliquefaciens 
FZB42. Mainly, degU, comA and hpr mutants were transformed with the whole promoter re-
gion via double crossover using the chromosome. The degU and comA mutant was used from 
the strain collection of our laboratory, while the hpr mutant was prepared in this study. The β-
galactosidase activity was studied for these regulatory mutants along with the wild type strain 
for comparison. 
With this approach, several regulators involved in bacilysin were identified. The most im-




were found to play a major role in the expression of bacilysin genes. DegU is the global regu-
lator involved in the regulation of degradative enzymes and initiation of competence. ComA 
is the regulator of late competence genes and surfactin production. Apart from these positive 
regulators, Hpr and AbrB seem to play a negative role in controlling bacilysin synthesis. 
The expression in the degU mutant (AM12) is not completely silenced, while there remained 
a basal activity. It was probably due to the activity of the vegetative growth phase sigma fac-
tor, sigma A. The in silico binding site analysis of bac indicated three putative sites for DegU 
binding, which reflected the results of β-galactosidase assay. Since DegU acts as a positive 
regulator, its main role played could be to bring the distant sequences together for the efficient 
binding of RNA polymerase. 
 
Figure 13: β-Galactosidase activity in mutants. All the cultures were grown in GA medium. AA2 was the wild 
type strain compared to its mutant. AM10 has higher activity compared to wild type indicating its role as a nega-
tive regulator of bacilysin, whereas, AM12 and AM11 are mutant strains of degU and comA with low or no β-
galactosidase activity. 
The comA mutant , AM11, containing the longest promoter fragment showed no expression 
compared to the wild type and indicates a positive control of the bac promoter (see Fig. 13). 
There are only few reports so far for the direct binding of comA to promoter region [93]. It is 
not clear in case of the bacilysin promoter. 
Hpr (AM13) acting as negative regulator was also confirmed by lacZ expression. The activity 
was 2 fold higher than that of the wild type. It indicated a negative influence of Hpr over the 




mediate its effect on the bac promoter by direct binding to the promoter region. Therefore, it 
is confirmed that DegU, ComA and Hpr play a major role in full activation of bacA promoter 
mainly through the upstream region of 150 bp (-671 to +221 bp relative to transcriptional 
start). 
3.3.4 Transcriptional regulators of bacA promoter 
It was demonstrated in this work that the bacilysin promoter was influenced by several DNA 
binding transcriptional regulators using β-galactosidase assay. Especially, DegU, ComA and 
Hpr play a major role in attenuating the transcription of bac promoter. Furthermore, in order 
to confirm the role in activation, DNA - protein interaction studies were conducted using puta-
tive regulators. The results of these experiments are explained below in detail. 
3.3.4.1 Hpr and DegU directly affect pbac expression 
The two-component response regulators DegU and Hpr directly bind to the pbac promoter. In 
order to confirm that DegU has a role in full attenuation of pbac, (which is also evidenced by 
antibiotic sensitivity test and transcriptional lacZ fusion) the N-terminal His- tagged DegU 
protein was prepared and purified (see Materials and Methods). The nativity and functionality 
of the protein were confirmed by SDS-PAGE. The purified protein was used for EMSA and 
DNase I footprint studies. 
It was demonstrated in this work that the bacA promoter was significantly influenced by the 
regulatory protein Hpr using lacZ reporter assay. Furthermore, to check, whether the Hpr pro-
tein binds to the bacA promoter, Hpr protein was prepared using an expression vector in E. 
coli (see Materials and Methods).  
3.3.4.2 EMSA indicates direct binding of DegU and Hpr to pbac 
The results from lacZ fusion and antibiotic sensitivity test indicated the positive role of DegU 
in the transcription of pbac. The full length fragment (-671 to +221 bp relative to transcription-
al start) of the bacA promoter was used to study the gel retardation of both DegU and DegU~P 
proteins. Increasing concentrations of protein were used in each experiment. The result indi-
cated that DegU has specific binding sites on the pbac promoter and is essential for the full 




0.5 µM of unphosphorylated DegU (see Fig.14). A delay in migration of the promoter frag-
ment was observed with increasing concentration of DegU and DegU~P reaching a saturation 
level at 3.0 µM. Binding of DegU was more specific, since the incubation of promoter DNA 
with the same amount of non-specific protein (poly dI-dC) did not lead to shift under the same 
conditions. 
To investigate, whether Hpr binds to the promoter region of bacA to directly control transcrip-
tion, I applied an electro-mobility shift assay. The experiments indicate binding of Hpr to pbac 
promoter. This is the same fragment used in constructing transcriptional reporter fusion to 
monitor bacA expression. 
 
Figure 14: Gel retardation of DegU, DegU~P and Hpr on pbac A) indicates the binding of DegU to pbac. With 
raising concentrations, the binding of DegU became stronger and reached a saturation level at 3.0 µM. B) De-
gU~P also caused a visible shift similar to the unphosphorylated form C) Indicates the binding of Hpr. In this 






3.3.4.3 Footprinting of DegU and Hpr binding sites 
The binding of DegU to the pbac and phpr was confirmed by gel retardation assay. Furthermore, 
the specific binding sites were identified using DNase I footprinting. The fragment (264 bp) 
of pbac containing the entire length of the promoter was radiolablled and treated with DNase I 
along with the increasing concentration of regulatory protein, DegU. The protection of bac 
promoter was observed in the footprints. It revealed three different binding sites between -125 
to -98, -82 to -74 and -57 to -5 within the coding strand of bacA promoter region.  These re-
gions were spanned by hypersensitive sites indicated by yellow arrows heads. On the non-
coding strand only one protected region (-65 to -35) flanked by hypersensitive sites was found 
(see Fig.15). Furthermore, the protection indicated that adenine and thymine were the pre-
ferred bases for DegU binding. The region of this protection includes promoter elements like -





Figure 15: Mapping DegU binding sites. The DNase I footprint represents the binding of DegU to the promoter 
region of bacilysin. A) P32 labelled forward primer (bacFP1a) DNA sequence was digested with DNase I 
while the whole sequence was PCR synthesized before digestion. The digested product was separated us-
ing a 7 M denaturing urea gel. B) The bacFP3b (antisense strand) was labelled and digested along with 
DegU. Binding of DegU to the antisense strand was not so strong as to the sense strand; however, there 
were few hypersensitive bands indicating the dynamics between DegU and DNA strand. Sequencing lad-
ders are marked as C, T, G, and A. 0 indicates the control with DegU protein and undigested DNA. The 
DegU concentrations raise (1.0 µM, 2.0 µM, 5.0 µM, and 10.0 µM) from left to right. The hypersensitive 
strands are marked by yellow arrows in both footprints and pink arrows representing disappearance of 
bands with increasing concentration of DegU. 
It was demonstrated in this study that Hpr acts as a negative regulator of bac genes using tran-
scriptional fusion assay. The electrophoretic mobility shift assay indicated the binding of Hpr 
to the bac promoter region. The P32 labelled forward primer bacFP2a was used to map the Hpr 
binding site on bacA (see Material and Methods). The labelled fragment was digested with 




moter. Site I (TTATCAATATTTTCAAATAATATTGACAG) included the region between -60 to -
31.Protections which covered the -35 region was also demonstrated in DegU footprint. 
This overlapping of regulators is the clue to how bacilysin might be controlled tightly during 
the vegetative growth phase. Site II (TATGGATAATATTTACTTAA) spanning between -20 to +6 
revealed the protection of -10 and +1 regions of the promoter (see Fig.16). Site III was deep 
inside the translational region of bacA. The protection spans between +26 to +47. Once again, 





Figure 16: Hpr-DNase I digestion of pbac. Mapping of Hpr binding site on pbac promoter. The sequencing lanes 
are marked as A, T, G, and C. The concentration of Hpr raises (1.0 µM, 2.0 µM, 4.0 µM, 8.0 µM) from left to 
right. The Hpr binds to the promoter of bacA and induces conformational changes which can be inferred through 
hypersensitive bands which are marked as blue arrows. The fragment between -90 to + 90 relative to the tran-
scriptional start point was used for DNase I digestion. The primers used for this fragment were indicated in ta-
ble.2 
3.3.5 Transcriptional regulation of ywfH in FZB42 
The ywfH is a monocistronic gene located downstream of the bac operon. It has been reported 
that YwfH has a putative nicotinamide- dependent reductase or dehydrogenase activity. It was 






In case of pywfH, the promoter region of ~600bp was fused to lacZ and transformed into 
FZB42. The resulting strain was referred as AA6. The expression of the ywfH gene was moni-
tored over the complete growth cycle. The ß-galacotosidase activity was measured. The ac-
tivity reached its maximum after 11 hours, an hour or two later when compared to bacA gene 
which can be assumed that the protein of ywfH is needed later for the synthesis of bacilysin. 
Thereafter, the activity decreased (see Fig.17).  
 
 
Figure 17: The in vivo transcriptional activity of pywfH. A) The gene map indicates the region used for analysis. It 
was not drawn to scale. B) A fragment of 600bp was fused with lacZ and transformed into AA0 resulting AA6. 
AA6 was grown in GA medium and β-galactosidase activity was assayed. In order to obtain DegU mutant 
(AM14), the chromosome of TF1, the degU mutant, was isolated and transformed into competent AA6 cells. β-
galactosidase activity was measured for both wild type and DegU mutant (AM14). It clearly indicated that DegU 
plays a major role as a positive indicator in the case of ywfH promoter. 
3.3.5.1 Two-component response regulator DegU binds to pywfH 
Interestingly, the gel retardation assay indicated a visible delay in the migration of ywfH pro-
moter when incubated with DegU regulator protein, clearly indicating that DegU plays a posi-
tive role in attenuating the ywfH gene expression. It was also shown in the transcriptional fu-




the binding of DegU. It represents +40 to -500 relative to the transcriptional start. Increasing 
concentrations of DegU were used in order to find the saturation level. 
 
Figure 18: EMSA indicated the binding of DegU to the ywfH promoter. The fragment started to shift at 3.0 µM 
and saturated at 6.0 µM. Increasing concentrations of DegU were used. Amounts are indicated in the figure. 
The binding of DegU to ywfH is important in the biosynthesis of bacilysin. EMSA revealed 
direct binding of DegU to DNA sequences of pywfH, but the exact binding regions cannot be 
assessed using this technique. They were detected by DNase I footprinting. 
3.3.5.2 Mapping DegU binding sites on pywfH 
Mapping of DegU binding sites in ywfH promoter was performed using DNase I. The promot-
er fragment covering -119 to +39 relative to transcriptional start was used for this study. La-
belling of this fragment was performed using P32 radiolabelled primers ywfHFw-FP and 
ywfHRw-FP. As a result, the PCR synthesized fragment was radiolabelled. Figure 19 repre-





Figure 19: Mapping of DegU binding sites on pywfH. Hypersensitive sites are shown as arrow mark. Binding 
region can be divided into two different sites although there is no clear boundary to detect. The concentration 
raises (1.0 µM, 2.0 µM, 5.0 µM, 10.0 µM) from left to right. The primers used for this study are indicated in 
table 2.2.3. The Sequence ladders used for this study are marked as A, T, G and C. 
From the footprinting patterns, it is clear that DegU binds to pywfH and the bound region can 
be seen as decreasing band intensities, when the concentration of DegU increased. The un-
phosphorylated DegU binds two distinct sites at the ywfH promoter inducing bends and local 
changes in the DNA architecture adjacently to these sites (seen as hypersensitive bands). In 
detail, the preferred bases of DegU binding include adenine and thymine. From the Figure 19, 
it is evident that the site I is composed of A and T’s (between -57 to -45) and has good con-
sensus to the reported sequence [94]. Site II ranges from -28 to -16. The promoter element -10 
is protected and also the transcriptional start (+1). Binding of DegU to such important pro-





3.4 Transcriptional regulation of hpr (pHpr) in B. amyloliquefaciens FZB42 
Hpr is a transition state regulator expressed by the hpr gene. It is a 23,7 kDa protein involved 
in the expression of neutral and alkaline proteases. Characterization and insertional inactiva-
tion experiments have shown that Hpr is a negative regulator of proteases [95]. Hpr appears to 
regulate not only proteases, but also other functions like alkaline phosphatase, motility and 
glucose mediated repression of sporulation [6]. Additionally, Hpr has shown to be a DNA 
binding protein in the regulation of proteases. It was demonstrated in this study that Hpr also 
acts directly on bacA promoter. While this report was in preparation, Inaoka et al. 2009 re-
ported the function of Hpr in bacilysin regulation. The footprint experiments in this work re-
vealed the exact binding sites of Hpr being the first report of Hpr footprinting in an antibiotic 
gene. 
3.4.1 β-Galactosidase assay for pHpr (hpr) 
In order to understand the expression of hpr at the transcriptional level, the promoter of hpr 
was fused to a lacZ reporter gene. The region selected encompassed the entire promoter in 
addition to extended upstream sequences (see Appendix 6.3 for sequence). PAK9 plasmid was 
used to construct the fusion. It is a vector which contains the flanking region of amyE and 
helps to integrate a single copy of construct into FZB42 chromosome (see Materials and 
Methods). Primers Hpr HindIII and Hpr SalI were used for the synthesis of PCR fragments. 
The fragments were digested using restriction enzymes (HindIII and SalI) and ligated into 
PAK9 vectors, referred as pAHN1. Plasmid pAHN1 was transformed into competent AA1 
strain (see Materials and Methods). Colonies were checked for the transformants which were 
named as AA7. Cells were grown in Difco sporulation medium for the complete growth cycle 
and the cells were collected. β-galactosidase activity was calculated and the gene expression 
pattern was indicated in the Fig.20. The activity was less compared to bacilysin assay. The 





Figure 20: β-galactosidase activity of hpr promoter. A) The fragment used for lacZ fusion was shown and not 
drawn to scale. B) Entire upstream and downstream region of hpr promoter was fused to lacZ and transformed 
into AA0, termed as AA7. Further, chromosome was isolated from AM07 and transformed into AA7 to obtain 
AM15 harbouring a mutant of abrB. Both cultures were grown in GA medium and β-galactosidase activity was 
measured. The mutant strain AM15 has completely lost its activity, when compared to the wild type strain AA7. 
The expression of hpr gene in the regulatory mutant strain of abrB (which was identified us-
ing in silico analysis) was studied. The hpr promoter was fused to lacZ gene and obtained the 
strain AA7 by transforming the FZB42 using this construct. The chromosome was extracted 
from mutant AM07 (∆abrB) and transformed into AA7. The obtained mutants was referred as 
AM15. β-galactosidase activity was calculated (see Fig.20). The disruption of abrB gene se-
verely affected the expression of hpr gene indicating the importance of AbrB. Obviously, the 
protein is required for the full activation of hpr promoter. 
3.4.2 Global regulator AbrB is controlling the expression of pHpr (hpr) 
Since it was evident from the in vivo transcriptional studies that AbrB plays a role in hpr ex-
pression, gel retardation assay was performed to narrow down the region that binds AbrB. A 
P32 radiolabelled fragment of ~600bp (PCR fragments synthesised with primers Hpr FPF1and 
Hpr FPF4) was used to study the shifting. The experiments revealed hindrance in the migra-
tion of promoter region indicating that hpr contains specific binding sites for AbrB. It is also 





Figure 21: EMSA indicated shifting of the hpr promoter with increasing concentrations of AbrB. The incubation 
of the hpr promoter with nonspecific polydI-dC did not cause migration of DNA fragments.  
Additionally, another interesting phenomenon was observed. It was known from previous 
experiments in our lab that AbrB has the ability to bind large DNA sequences (Neubauer, 
Pers.comunication). I designed primers in such a way that two fragments with overlapping 
regions were synthesized and radiolabelled using P32. They were subjected to EMSA. Surpris-
ingly, both the fragments shifted at the same concentrations indicating that the fragments har-
bour AbrB binding sites. 
 
Figure 22: Binding of AbrB to hpr. A) Fragment F1 showed partial binding of AbrB indicating that a sequence 
in the upstream region is essential for AbrB binding. B) Fragment F2, the downstream sequence of F1, indicated 
a shift even though the affinity of AbrB to the fragment was not so strong as that of the whole fragment (see Fig. 
21) 
Both these fragments exhibited affinity towards the AbrB protein. This can indicated that 
binding of a single AbrB molecule to the promoter might induce a cooperative binding of 





Figure 23: Representation of different fragments used in EMSA and footprint. The primers used to obtain these 
fragments are indicated in the table 2.2.3. The fragment F3 was used for the footprint. 
Furthermore, the DNase I footprint was performed in order to identify the exact location of 
AbrB binding. The footprinting obtained using F1 and F2 fragments did not indicate signifi-
cant binding of AbrB, while EMSA indicated a shift. The reason for this could be the sensitiv-
ity of the footprint. In order to solve this problem, a new fragment encompassing the whole 
fragment similar to the fragment used in EMSA (see Fig.21) was synthesized. The primers 
Hpr FPF1 and Hpr FPF4 were radiolabelled to generate PCR fragments. The complete frag-
ment was digested with DNase I. The resulting fragments were separated using 7M urea gel. 
The result obtained is shown in Figure 24. The footprinting obtained contains both the coding 
and non-coding strand leading to a similar conclusion that AbrB binds to the entire region of 





Figure 24: Footprinting of the hpr promoter with AbrB. The complete fragment of ~550bp was digested with 
DNase I and separated on a polyacrylamide gel. A) The forward primer fragment shows clear regions of the 
binding of AbrB to the hpr promoter. B) Represents the reverse strand; digested fragments indicate clear binding 
of AbrB to the entire region. The triangle represents the increasing concentration of AbrB. 0 indicates control. 
The concentrations of AbrB used are 1.25 µM, 3.75 µM, 7.5 µM, and 12.5 mM. The sequence used for footprint 




Based on this experiment, I am not able to locate exact sequences, where AbrB binds, since 
the protection was observed in the complete promoter region. The possible mechanism of 
binding is discussed in the last chapter of this thesis. 
3.5 Analysis of bacilysin synthesis in wild type and mutant strains of FZB42 
In order to quantify and check the production of bacilysin, HPLC and HPLC-MS was per-
formed in wild type and mutants. The culture was grown overnight in GA medium. The sam-
ples for HPLC and HPLC-MS were collected and the supernatant was used for analysis. A C18 
reverse phase column was used to separate bacilysin (see Material and Methods). The 
bacilysin peak appeared after 5 minutes of the total run of 25 minutes. It was detected at 
210nm. 
I have used RS06 (∆bacA, ∆sfp), a double mutant as a negative control for bacilysin produc-
tion. Regulatory mutants were checked for their production of bacilysin. As expected, mutants 
of degU (TF1) and comA (CH23) were affected negatively in their ability to produce bacilysin 
(see Fig. 25). On the other hand, hpr (AM10) mutant has similar or little higher activity com-
pared to the wild type FZB42. Once again, the role of regulatory mutants has qualitatively 
been proved to be essential for bacilysin biosynthesis.  
We were expecting a higher production of bacilysin in case of hpr mutant (AM10) but, sur-
prisingly the amount of bacilysin detected was similar to the wild type. To find a reason for 
this phenomenon, we have checked the production of bacilysin using protease inhibitor mix-
ture which contains alkaline protease inhibitor (as supplied by Sigma) since alkaline protease 
has been associated with degradation of bacilysin [96]. Always after using the protease inhibi-
tor in culture medium, there was no marked increase in bacilysin production.  It was indicated 
in the earlier part of this thesis that the ywfH gene is essential for the complete biosynthesis of 
bacilysin. We hypothesize that the other reason could be the negative control of protein regu-
lators which are acting on ywfH gene. So far, there is no clear evidence of these negative regu-
lators acting on this gene. However, in silico analysis indicated the presence of nitrogen regu-
lators such as CodY and TnrA on the promoter region. To a certain extent, AbrB has also been 
shown to shift the ywfH promoter region but not in the range of biologically available amount 









Figure 25: HPLC analysis of bacilysin production. The wild type and mutants were grown in GA medium over-
night and the supernatant was collected and analyzed using HPLC. The samples were marked above. In each 
chromatogram the bacilysin peak appeared at 5th minute of 25 minutes of total run. Bacilysin was indicated by 
red round on each sample.  
High performance liquid chromatography (HPLC) combined mass spectrometry was also per-
formed. Extracted ion chromatograms (EIC) were shown in the Figure 26. The analysis re-
vealed the confirmation of previous results that DegU and ComA positively regulate 
bacilysin, while Hpr negatively controls this dipeptide antibiotic. In case of HPLC-MS, the 
chromatogram from mutants (TF1 and CH23) did not indicate a complete loss of bacilysin, 
whereas the HPLC chromatograms indicate loss of the bacilysin peak in these mutants. It was 
shown earlier in this study that B. amyloliquefaciens FZB42 retained some basal activity. 
Apart from this phenomenon, the sensitivity of the column and the method might be the rea-
















Figure 26: HPLC-MS of bacilysin. Different regulatory mutants were grown overnight in GA medium, the su-
pernatant was collected and analyzed using HPLC-MS of Thermo scientific make. The extracted ion chromato-
grams (EIC) indicate the mass of bacilysin which is 271.0 Dalton. In the wild type, the mass appears in large 
amount whereas in regulatory mutants (comA and degU) only little of bacilysin was available. RS06 was used as 
a control since it is a knock-out mutant of bacA and sfp. The orange round indicates the abundance of bacilysin 
in different samples. 
The analytical analysis of bacilysin using HPLC and HPLC-MS indicate the importance of 
regulators in bacilysin biosynthesis. I have tried to quantify bacilysin; however it was not suc-
cessful due to the unavailability of pure bacilysin to compare as standard. HPLC-MS chroma-
togram was further analysed by expanding the region around m/z 271 kDa. The regulatory 











4 Discussion  
The results reported here provide new insights into the regulation of bacilysin genes at the 
molecular level, which has been a subject of study for more than a decade. The bac operon 
and the monocistronic gene ywfH for bacilysin production were studied at the promoter level. 
I have also demonstrated here that DegU and Hpr act together in the expression of bacilysin. 
The DegU plays the role of a positive regulator, while Hpr negatively controls bacilysin pro-
duction in FZB42. On the other hand, ywfH has also been found to be controlled by DegU. 
There was no negative control from Hpr. The overall regulation of bacilysin production ex-
emplifies transcriptional regulation of a gene involved in this process during vegetative and 
the transient growth stage of FZB42. 
4.1 Promoter analysis of bacilysin genes and the ywfH gene 
The promoter of bacilysin genes can be recognised as a well organised and utilized promoter 
by protein regulators of DNA binding class. The structural elements of the promoter, especial-
ly -35 (5’TTGACA3’) and -10 (3’TAATAT5’) are well conserved and correspond to the re-
ported consensus [97]. Apart from these regular hexamers, there are -16 (TATG) and putative 
UP element which are present in the promoter of bacilysin. It was proposed more than a dec-
ade ago that optimal promoter activity is achieved by different combination of promoter ele-
ments which include not only the -10 ad -35 hexamers which are recognized by the σ70 subu-
nit of RNAP, but also upstream and downstream sequences [98-100].  
In addition, it was recognized in E. coli and B. subtilis that RNAP protects regions of both 
upstream and downstream of -10 and -35 hexamers in the footprint [101-103]. The in vitro 
transcriptional studies indicate binding of RNAP accelerated by A+T rich upstream regions of 
-35 hexamer [104]. UP elements, components located upstream of -35 help in transcription by 
increasing the binding affinity of RNAP α-subunit [105]. UP elements are not highly con-
served as -10 and -35 elements [106]. However, A+T rich regions were identified as promi-
nent features of a subset of E. coli, B. subtilis and Clostridium promoters. Gorse et al. report-




are several bases upstream of promoter function as UP elements which have different effect 
on varied promoters [107]. 
An UP element was identified upstream of -35 region in the bacilysin promoter. The UP ele-
ment (-54 TATTTTCAAATAAT -41) of bacilysin shares nine out of 10 nucleotides to the re-
ported consensus [107], and overlaps the DegU binding site. Apart from the hexamers and the 
UP element, the ribosome binding site (RBS) of the bacilysin promoter is not well conserved. 
It is mainly composed of T+G bases, whereas adenine bases are commonly found in RBS, 
however, in B. subtilis 168 RBS is well conserved. The reason for the differences in RBS be-
tween B. subtilis and B. amyloliquefaciens FZB42 is still unknown. Nevertheless, the RBS of 
FZB42 can be utilized and substituted by conserved bases in order to increase the production 
of bacilysin in the host cell. 
Similarly, the promoter of ywfH has been analysed in this study. Essential promoter elements 
like -10 (TCATT) and -35 (TTAAAT) are not well conserved. It contains no conserved UP 
element. At the same time, the RBS of ywfH is highly conserved, when compared to bacA 
promoter. 
4.2 Transcriptional regulators of bacilysin 
The promoter of bacilysin could be envisaged as a well utilized promoter directed by several 
DNA binding regulators. Several studies have already revealed that bacilysin is influenced by 
global and metabolic regulators [80, 108]. Table.8 represents regulators reported from differ-
ent studies. 
Table 8: Regulators involved in bacilysin production. 
Regulators Effect on bacilysin Reference 
ywfA + [78] 
thyA + [81] 
opp + [80] 
spo0A + [80] 




comQ/comX + [80] 
comA and phrC + [80] 
srfA + [80] 
codY - [78] 
abrB - [80] 
 
However, the effects of these regulators were not studied at transcriptional level. Most of 
them are indirectly involved in the regulation of gene expression. For example, it has been 
shown that bacilysin production and ComA are linked, while it has been understood from our 
study that ComA is indirectly regulating bacilysin through other mediators, like DegQ [66]. 
The sections below will describe extensively the global and other kind of regulators involved 
in the production of bacilysin. 
4.2.1 DegU positively regulates bacilysin and ywfH 
DegS-DegU controls various processes that characterize the transition from the exponential to 
the stationary phase in B. subtilis. It includes induction of extracellular degradative enzymes, 
expression of late competence genes and down-regulation of σD regulon [109]. Changes in the 
cell environment are often sensed by bacterial two-component systems consisting of a sensor 
kinase and its cognate response regulator. The autophosphorylating histidine protein kinases 
sense the stimulus, and transfer their phosphoryl group to a conserved aspartate residue of 
response regulator [110]. DegU has been shown to be a master regulator of multicellular be-
haviour and the genes within the regulon respond in a different manner to the level of De-
gU~P [111-112]. In addition, It has been reported that DegU controls swarming and biofilm 
formation [113]. Furthermore, DegU has been associated with salinity tolerance in B. subtilis 
[114]. 
DegU belongs to the LuxR-FixJ family whose members have a helix-turn-helix (HTH) struc-
ture at their C-terminus [115]. DegU has been attributed to two modes of action: the phos-
phorylated form of DegU~P acts directly on degradative enzyme biosynthesis (aprE and 
nprE), whereas unphosphorylated DegU binds to the comK promoter enhancing transcription 




amino acids referred as DegQ and DegR, respectively. The expression of these genes also 
depends on the DegSU system [109]. It has been reported that DegQ stimulates phosphotrans-
fer from DegU~P to DegU in vivo and DegR helps in stabilization of phosphorylated DegU 
[109, 115, 117]. In addition, degQ expression was shown to be regulated by the ComP-ComA 
two-component system. Recently, it was reported that DegU expression is controlled by three 
different promoters. The first is located upstream of the degS gene, the second promoter 
downstream of degS and third in front of degU. It has been shown that the third promoter of 
degU is controlled by nitrogen limitation regulators such as GlnA and TnrA [118-119]. 
 
In my case, DegU activates bacilysin expression at vegetative and transition growth stages. 
The experiments in this study were conducted using unphosphorylated DegU. Parallel exper-
iments were performed with DegU phosphorylated using acetyl phosphate. The results ob-
tained were similar in both cases. Initial experiments, like lacZ reporter fusion, have clearly 
demonstrated that in absence of DegU FZB42 failed to produce bacilysin (see Fig. 13). 
 
Figure 27: Schematic representation of DegU regulation on bacilysin production. 
Furthermore, DNA-protein interaction studies were carried out so that the effect of DegU on 
pbac can now be deciphered. EMSA indicated that DegU binds to the pbac directly and a small 
quantity (0.5 µM) of protein was enough to shift the promoter fragments. The fragment used 
for the EMSA covered the entire promoter region (-170 to +22 relative to the transcriptional 
start). 
DNase I protection studies revealed new insights into DegU binding sites. They revealed two 




(see Fig.15). It agrees with several other studies of DegU footprinting [94, 113, 120]. The 
pattern of DegU binding to pbac raised important questions regarding the mechanism of such 
classes of DNA binding proteins. Interestingly, despite differences in promoter structure simi-
lar binding effects of DegU were observed on pywfH and pbac. Both possess two binding sites, 
at -64 to -15 and at -4 to +22 relative to the transcriptional start site. So the nature of DNA 
binding can be derived from this and previous studies of bmyD promoter by Koumoutsi et al. 
It seems that several molecules of DegU are required to activate the promoters (see Fig.28) 
[66]. 
 
Figure 28: The interaction of DegU and RNA polymerase with the bac promoter. 
 DegU mainly prefers to bind at the A/T rich base region which was demonstrated in this the-
sis, but the binding of DegU to the bac promoter is weaker compared with Hpr. This could be 
due to DegU binding sites which are also similar in case of bacilomycin D, where DegU acts 
positively [66]. Nevertheless, this study indicates, how DegU might activate the bacilysin 
promoter. The two DegU binding sites in pbac and pywfH are clues to the function of DegU. It 
could be possible that DegU bends the DNA and alters its structure in order to the binding of 
RNA polymerase, a mechanism which is common for the activation by protein regulators 
[88].  
Apart from this regular mechanism, it could be possible that multimerisation of DegU plays a 
role in DegU binding at the target sequence, as it has been found in the case of phyC promoter 
reacting with the global regulator AbrB [121]. Meanwhile, a study was published about the 




tandem repeat of a 5-nucleotide sequence (TAAAT) or an inverted repeat of (ATTTA-N7-
TAAAT) [120, 122]. Such a phenomenon of DegU binding was also observed in our case (see 
Fig.15). However, in order to find the exact binding sites more elaborated studies, like site-
directed mutagenesis and hydroxyl foot printing, have to be performed. 
Finally, it was clearly demonstrated that DegU plays a major role in the expression of 
bacilysin by positive regulation. The initial signals perceived by DegU are still unclear. Our 
experiments demonstrate that unphosphorylated DegU is more efficient in bac promoter bind-
ing than the phoshorylated one. According to our results, unphosphorylated DegU is also con-
trolling cellular activities, but at this stage it is not clear, whether unphosphorylated DegU acts 
during the vegetative growth cycle especially to control special genes, like bacilysin [123]. 
However, unphosphorylated DegU has been shown to directly stimulate competence through 
the comK promoter [113]. DegU has an opposing effect on the DNA uptake gene cascade, it 
coactivates and represses comK and the srf operon, respectively. Therefore, it inhibits comS 
which is residing inside the srf operon [114]. A genome-wide transcriptional profiling using 
the degU regulon (along with degS mutant) indicates that a delicate balance between the 
amounts of phosphorylated and unphosphorylated DegU is important in controlling the genes 
[124]. 
Hpr negatively regulates the bac promoter 
Hpr encoded by hpr (scoC) is a transition state regulator of DNA binding proteins. It belongs 
to the MarR family of regulators referred to their control of multiple antibiotic resistance 
genes in Gram-negative bacteria [125]. Homologs of MarR family are distributed throughout 
the bacterial and archaeal domains. It has been suggested that the MarR family serves as sen-
sors of changing environments. ScoC (Hpr) was first identified by mutations leading to in-
creased synthesis of alkaline (aprE) and neutral (nprE) protease in B. subtilis [126]. 
 
Characterization of mutants and insertional activation has shown that Hpr acts as a negative 
regulator. It acts directly on the transcriptional level, while in case of subtilisin it can be con-
sidered as a temporal regulator indirectly involved in gene regulation. Recently, it was shown 
that phoPR, which mainly regulates the majority of the genes induced during phosphate star-




tions performed with multicopy senS and mutants of salA indicate that the product of both 
these genes control hpr (scoC) expression [128-129]. In most of these studies, Hpr was shown 
to act as negative regulator either directly or indirectly affecting gene expression. 
 
This study is the first which is analysing the effect of Hpr on an antibiotic gene by decipher-
ing the binding site using DNase I footprint (see Fig.16). I have demonstrated that Hpr binds 
to the promoter of bacilysin in order to negatively regulate the bacilysin production during the 
active growth stage of bacteria. It is still unclear what makes the expulsion of Hpr from the 
DNA recognition helix and the binding of DegU to this region. It was observed that DegU and 
Hpr bound at similar elements of the DNA recognition helix. The DNA binding domains of 
MarR proteins adopt a conserved winged helix-turn-helix. The winged helix DNA binding 
motif is defined topologically by secondary structure elements arranged in the following or-
der: H1-S1-H2-H3-S2-W1-S3-W2, where “H” represents α-helix, “S” represents β-strand and 
“W” represents a loop [130].  
 
However, a report suggested a possible mechanism of DNA recognition by the MarR family 
of regulators using molecular-dynamics-guided-mutation analysis. It was shown that the ami-
no acid at position W20 from the N-terminal helix and R80 from helix 3 serve as a scaffold 
for the DNA recognition helix [131]. Here in this study of bacilysin, I have demonstrated 
binding of Hpr to the pbac promoter at three different sites. It was not clear, why Hpr footprint-
ing indicated three distinct binding sites, while the study on the protease promoters footprints 
indicate two binding sites for Hpr [6]. We postulate that Hpr belongs to the family of winged 
helix-turn-helix proteins acting due to the nature of available cognate DNA binding motif. 
The sites on the pbac promoter which were protected by Hpr covered nucleotide from -60 to 
+47 relative to the transcriptional start site. It protects important promoter elements, like -35 
and -10. DegU and Hpr share common elements of DNA binding motifs. Therefore, the inter-
action between Hpr and DegU is essential for the modulation of bacilysin expression. 
 
4.3 Indirect control mechanisms of bacilysin production 
Several global regulators were found to indirectly influence bacilysin production at transcrip-





4.3.1 ComA positively controls the expression of bac genes through DegQ 
ComP-ComA belongs to the family of two-component systems activated by cell-density sig-
nals [132]. It is known to control several central developmental processes in the cell. The 
phosphorylated ComA activates the srfA operon, a first step towards the competence devel-
opment [93]. srfA encodes an enzyme complex catalyzing the synthesis of the lipopeptide 
antibiotic, surfactin along with the competence regulatory gene comS which lies within the 
srfAB gene but out of frame. In addition, ComA stimulates the expression of degQ, rapA and 
rapC [133]. Moreover, ComA destabilizes the MecA-ClpC/ComK ternary complex by releas-
ing ComK which is degraded subsequently [134].  
We have found in our study that ComA influenced bacilysin production in a positive manner. 
The lacZ reporter fusion studies indicated that the activity of the β-galactosidase is completely 
reduced in the absene of ComA , implying that ComA is strictly controlling bacilysin biosyn-
thesis in B. amyloliquefaciens FZB42. However, we have not studied the DNA-protein inter-
action, because ComA mainly acts indirectly [66]. It was shown in this study that DegU 
bound to the promoter of pbac at -91 to +22. Therefore it is not possible that many regulators 
are involved at the same time in gene expression due to space constraint. Simultaneously, 
ComA regulates DegQ which in turn regulates DegU. So, ComA exerts its effect mainly via 
degQ expression [7]. In addition, the consensus for comA promoter has already been identi-
fied. It consists of a palindromic sequence, named ComA box, i.e. TTGCGG-N4-CCGCAA 
[135]. Searching for consensus in pbac does not yield any of such motifs within the promoter 
sequence corroborating our postulation that ComA acts indirectly. 
4.3.2 AbrB negatively controls bac gene through expression of Hpr 
The suboptimal environmental conditions of bacteria push them into different lifestyles. One 
of such transitions takes place with the help of global regulator proteins which are controlling 
gene expression during the exponential growth stage. The transition state protein AbrB is one 
of the global regulators controlling several genes that commence expression at the end of veg-
etative growth and the onset of stationary phase [136-138]. The range of genes includes bio-




take genes, competence and sporulation. More than 20 genes have been attributed harbouring 
specific binding sites for AbrB [139-140]. However, the hpr promoter did not reveal any se-
quence that can be assigned to an AbrB conserved binding site [141]. AbrB is a DNA binding 
protein of 10.4 kDa composed of two domains. The stable DNA binding site of AbrB is 
formed through two N-terminal domains and a dimer of the C-terminal region [142-143]. The 
N-terminal region of AbrB forming a single binding domain is referred as a swapped-hairpin 
barrel. Furthermore, AbrB orthologs and paralogs have been found in genomic sequences of 
all Bacillus, Clostridium and Listeria species, and AbrB have been shown to be involved in 
induction of virulence factors in B. cereus and B. anthracis [144]. 
 
At the onset of sporulation and stationary phase, many genes that are under the control of 
AbrB are relieved through the action of phosphorylated Spo0A [145] The phosphorylation of 
Spo0A is achieved through a multicomponent phosphorelay involving five histidine autoki-
nases (KinA, KinB, KinC, KinD and KinE) and two phosphorelay proteins Spo0B and Spo0F 
[146]. Once the concentration of Spo0A increases, the amount of AbrB depletes through the 
negative regulation of the former protein. 
 
Surprisingly, we found that AbrB positively regulates the hpr promoter by direct binding. The 
lacZ reporter fusion study has revealed that AbrB is a positive regulator of Hpr. The promoter 
fragment, similar to that used for lacZ fusion, was used in EMSA assay. Experiments revealed 
direct binding of AbrB. Since we knew from earlier studies that AbrB binds to a large promot-
er region (Neubauer pers. communication), I also analysed the promoter region by subjecting 
two smaller DNA promoter fragments to EMSA. Surprisingly, both of the fragments showed 
affinity to AbrB.  
 
Based on these results, I performed DNase I footprint for the two shorter fragments, however, 
it did not reveal any AbrB binding sites using this method. To solve the problem, I have used 
the whole fragment (see Fig. 23). In this case binding of AbrB was observed. On the other 
hand, AbrB bound to the whole region without specifying any consensus sequence. Although, 
the protein has been studied extensively both biochemically and genetically, it is still unclear, 
how AbrB binds to the target by selecting binding sites on DNA. To date, examination of 




quence. Alternatively, it has been hypothesized that AbrB requires a specific three-
dimensional structure of DNA for binding [142, 147]. 
Recently, a nuclear magnetic resonance (NMR) study of AbrB yielded a new insight into the 
complex between the N-terminus of AbrB and the DNA-binding sequence. The flexibility of 
loop regions LP1and LP2 are considered to be important for the binding of AbrB to various 
DNA targets which are thermodynamically favourable [148-149]. Similarly, in our study we 
demonstrated direct binding of AbrB to the hpr promoter. Binding occurred at the entire pro-
moter and also in the adjacent upstream sequence of the nearby gene yhaH. It might be possi-
ble that an AbrB monomer initially bound somewhere at the promoter region and is initiating 
formation of a long stretch of multiple proteins covering large parts of the promoter and its 
adjacent regions.  
 
Figure 29: Model AbrB binding to the hpr promoter. Several molecules of AbrB are necessary in order to bind 
the whole promoter region.  
 
Distribution of AbrB binding sites in vivo over the entire B. subtilis chromosome has been 
reported by Ishikawa et al. [150]. The study includes not only AbrB, but also its paralog, Abh, 
whose overall identity is 58% to AbrB. It indicates several new insights into the genes con-
trolled by AbrB on a global scale and also its relation towards Abh. It was shown that almost 
all Abh-binding sites overlapped with the sites for AbrB. Further, in vivo cross-linking indi-
cated the existence of AbrB-Abh complexes in wild type cells. Consequently, the Abh would 
form monomers, when the cellular levels of AbrB decrease. At this stage, AbrB and its ortho- 
and paralogs need more studies in order to assign their role in the bacterial cell. 
 
4.4 Comparing the regulation of bacilysin and bacillomycin D in FZB42 
Bacilysin and Bacillomycin D are synthesized at different growth stages of FZB42. Both are 




pendent. Bacilysin consists of two amino acids which are synthesized through few reaction 
steps involving reductase and ligase activities, whereas bacillomycin D is synthesized using 
the multicarrier thiotemplate model. A search for similarity on nucleotide level did not yield 
any conserved promoter elements between these two promoters. However both bmy D (bacil-
lomycin D) and bacA promoters utilize sigma A (σA) dependent RNA polymerase for the tran-
scription. At the level of transcription both promoters require the common global regulator 
DegU. For full activation DegU prefers A/T rich bases in both promoters. 
The DegU has two forms of activity i.e. phosphorylated and unphosphorylated. It was shown 
in case of bacillomycin D that the phosphorylated form of DegU has a higher affinity to the 
bacillomycin D promoter region. In case of bacilysin, both forms of DegU were investigated 
and I found that the unphosphorylated form of DegU has higher affinity to both, the bac and 
the ywfH promoter. The reason for such differences could be that syntheses of these peptides 
occur at different growth stages. Bacillomycin D is synthesized during the stationary phase of 
FZB42. During this stage, the phosphorylated form of DegU is predominant and the phos-
phorylation state is maintained through DegQ and DegR. In the case of bacilysin the unphos-
phorylated form of DegU is predominant which is synthesized during the active growth stage. 
It has a stronger activity compared to the phosphorylated form. The mechanism by which De-
gU acts on its DNA target is similar for the promoters of both bacA and bmyD. It is character-
ized by bending of DNA, creating local conformation changes in order to support RNA poly-
merase. This idea is based on the hypersensitive bands which are observed in DNase I 
footprinting. 
Finally, ComA, a competence stimulating factor, affects both bacA and bmyD. While DegU 
binds directly to these promoters, ComA affects indirectly via DegQ. This assumption was 
supported by the absence of ComA boxes in these promoters. However, in case of DegQ there 
was an evidence for the presence of such ComA boxes occurring in B. subtilis as well as in B. 
amyloliquefaciens FZB42.  
4.5 Summary of the control of bacilysin synthesis in FZB42 
In this work, it was demonstrated that the expression of bacilysin genes is influenced by sev-




competition between Hpr and DegU, I tried to perform some competition studies involving 
both DegU and Hpr indicating that DegU bound to the bac promoter sequence more intensely 
than Hpr. Since I performed footprint studies (see Fig.15 and Fig.16), it was clearly under-
stood that the arrangement of binding sites on the bac promoter may induce a space competi-
tion between these regulators. The DegU protein was identified to contain three binding sites 
within the bac promoter which clearly indicates that binding of a single DegU molecule might 
induce the recruitment of many DegU proteins to the promoter, so that it creates a space com-
petition with Hpr, eliminating this negative regulator. However more detailed studies have to 
be carried out.  
There are several regulators mediating expression of the bacilysin dipeptide indirectly and 
some of them were found influence either DegU or Hpr. We propose here an overall scheme 
describing our present knowledge of the control of bacilysin production (see Fig.30). Initial 
signals were perceived under nitrogen limitation and mediated by CodY and TnrA/ GlnR 
whose functions are to control several metabolic genes [151-152]. Recently, it was shown that 
GlnA mediates DegU synthesis via TnrA [66, 118-119]. In our study we have demonstrated 
that DegU is a major factor in regulating bac genes expression. Furthermore, I searched for 
CodY and TnrA/ GlnR binding sites on the promoter of the com-QXPA operon. It revealed the 
presence of binding motifs to the regulators. Expression of this operon is essential for the 
competence development and synthesis of surfactin through ComA [93]. We have also shown 
here that ComA is essential for biosynthesis of bacilysin.  
A similar search for binding motifs of AbrB within hpr promoter revealed the presence of 
such motifs. We confirmed binding of Hpr by performing DNA-protein interaction studies 
(data not shown). So, we propose that AbrB mediates the expression of hpr gene, which in 
turn controls the bacilysin production. Then, activation of Spo0A negatively controls AbrB, 
relieving its effect on the target genes which are under the repressive effect of this global reg-
ulator [153]. Hpr which is under the positive control of AbrB is now lowered in the cell, and 
DegU can fully activate the bacilysin promoter. Unfortunately, the data obtained from HPLC 
analysis of the hpr mutant (AM10) did not indicate a higher production of bacilysin. While 




reaction catalysed by the ywfH gene product remains still a bottle neck in synthesizing the 
mature bacilysin dipeptide, since expression of that gene is not relieved by removing Hpr.  
 
Figure 30: Regulatory network of bacilysin production. Several global regulators are directly or indirectly regu-
lating bacilysin. However, DegU and Hpr are directly acting on the bacA promoter. 
 
Consequently, our bacilysin study opened some new details concerning the overall regulation 
of an antibiotic synthesis. The key mechanisms that control the bacilysin biosynthesis by 
global protein regulators were studied. In the future, using these results the production of 
bacilysin in B. amyloliquefaciens FZB42 can be increased. A strain with increased antibiotic 
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6 Appendix  





Figure 31: Sequence of the bacA promoter used in this study is given above. The primers used for footprint are 
indicated. Different regulators acting on the promoter were also indicated.  
6.2 Promoter sequence of ywfH promoter 
 
Figure 32: Represents the entire promoter region used for the study of ywfH gene. Primers used for footprint 





6.3 Promoter sequence of hpr promoter 
 
Figure 33: Indicates the promoter region of hpr gene. The primer used for the footprint was represented as Hpr 
FPF.  
 
6.4 Purification of DegU protein 
 
Figure 34: DegU was purified as given in materials and methods. On the SDS gel, 1 = protein marker, 2 = cell 
extract, 3 = flow through, 4 = wash1, 5 = wash 2, 6 = elution 1, 7 = elution 2, 8 = elution 3, 9 = elution 4. The 








6.5 Purification of Hpr protein 
 
Figure 35: Hpr is a 27 kDa protein. The SDS gel represents the purified Hpr. 1= protein marker, 2 = Hpr protein 
eluted using elution buffer (see Materials and Methods).  
6.6 Comparison of Pbac in FZB42, B. subtilis 168, and DSM 7 
 
Figure 36: The above data clearly indicate the identity of the pbac promoter in three different closely related 
strains. FZB42 and B. subtilis 168 are rhizosphere colonizers, whereas DSM 7 has no such attributes. However, 





Figure 37: Multiple sequence alignment of three closely related strains. From the figure, the first 20 bases were 
shown to be involved in DegU binding and it can be clearly seen there that B. subtilis lacks the conserved do-
mains for such binding. So, FZB42 efficiently controls the synthesis of bacilysin. However, the other promoter 
elements like -35 and -10 are well conserved among these strains. On the other hand, the SD sequences are com-












6.7 Comparison of PywfH in FZB42, B. subtilis 168, and DSM 7 
 
Figure 38: The alignment score reveals the distance between the strains for the ywfH promoter. FZB42 and DSM 




Figure 39: Most of the essential promoter elements of ywfH gene are well conserved among these strains. How-







6.8 Comparison of Phpr in FZB42, B. subtilis 168, and DSM 7 
 
Figure 40: Similarity scores of the different Bacillus strains indicate that the promoter of hpr is closely related 




Figure 41: Sequence comparison indicates the conserved nature of promoter elements between the closely relat-





















Hiermit versichere ich, die vorliegende Dissertatoin selbstständig verfasst und 















• Aruljothi Mariappan, Xiao-Hua Chen, Oliwia Makarewicz Alexandra 
Koumoutsi and Rainer Borriss. Two- component response regulator DegU 
controls the expression of bacilysin in PGPR - Bacillus amyloliquefaciens 
FZB42, Submitted for publication. 
 
• Aruljothi Mariappan, Oliwia Makarewicz and Rainer Borriss. AbrB posi-
tively regulates hpr (scoC) by directly binding to the hpr promoter of Ba-
cillus amyloliquefaciens FZB42. Manuscript in Preparation. 
 
• Wukun Liu, Kerstin Bensdorf, Ulrich Abram, Ben Niu, Aruljothi 
Mariappan, Ronald Gust. Synthesis and biological studies of silver N-
heterocyclic carbene complexes derived from 4,5-diarylimidazole. Eur J 














This thesis would have not been possible unless I specially thank Prof. Dr. Rainer 
Borriss for giving me a wonderful opportunity to work in his group. He has been 
constantly supporting my work by meticulous supervising and constructive ideas. 
I would also like to thank him for his interest in my future career.  
I thank Dr. Joachim Vater for accepting to act as second referee. I am indebted to 
him for giving extensive revision to my thesis. I would like to heartfully thank Dr. 
Xiao Hua Chen for her constant encouragement and support in preparing several 
mutants as well as for the promoter analysis of Bacilysin.  
My special thanks to Dr.Oliwia Makarewicz who helped me to perform several 
DNA-Protein interaction studies and also helped with my thesis and publication. 
Her help greatly improvised my work. I thank Dr.Süsmuth and Ms.Manuela of TU 
Berlin for their support in performing HPLC analysis. 
 I also extend my thanks to Prof. Dr. Thomas Eitinger, Prof. Dr. Rudolf Ehwald 
and Prof. Dr. Wolfgang Lockau to act as referees. 
 
I owe my deepest gratitude to my colleagues of my working group. I thank Fan 
Ben, Kinga, Lilia, Niu Ben, Qiao, Yuvan, Anto, Romy, Eva, Kristin, Tom and 
Svetlana for their wonderful support. They made my environment colourful. They 
also extended very warm discussions which improved my scientific thinking. I 
also thank Ms.Christiana Müller for her excellent organisation of laboratory things 
which greatly helped us to push our work.  
I am indebted to my beloved wife Ms. Sella Anitha who took care of me very well 
so that I concentrated on my work and to successfully complete my thesis.  
Finally, I am here because of my family, I thank them wholeheartedly.
